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The gram-positive bacterium Staphylococcus aureus is a fre-
quent component of the human microbial flora that can turn into
a dangerous pathogen. As such, this organism is capable of in-
fecting almost every tissue and organ system in the human body.
It does so by exporting a variety of virulence factors to the cell
surface and extracellular milieu of the human host. Like all living
organisms (201), S. aureus contains several protein transport
pathways, among which the general secretory (Sec) pathway is the
most well known and best described. Proteins that need to be
transported to an extracytoplasmic location generally contain an
N-terminal signal peptide that is needed to target the newly syn-
thesized protein from the ribosome to the translocation machin-
ery in the cytoplasmic membrane. Next, the protein is threaded
through the Sec translocon in an unfolded state. During this
translocation step, or shortly thereafter, the signal peptide is re-
moved by a so-called signal peptidase (SPase). Upon complete
membrane translocation, the protein has to fold into its correct
conformation and will then be retained in an extracytoplasmic
compartment of the cell or secreted into the extracellular milieu.
In the case of gram-positive cocci, such as S. aureus (Fig. 1), we
distinguish three extracytoplasmic subcellular compartments,
namely, the membrane, the membrane-cell wall interface, and the
cell wall. Since surface-exposed and secreted proteins of S. aureus
play pivotal roles in the colonization and subversion of the human
host, it is of major importance to obtain a clear understanding of
the protein transport pathways that are active in this organism
(103). Knowledge about the protein sorting mechanism has be-
come all the more relevant with the emergence of staphylococcal
resistance against last-defense antibiotics, such as vancomycin.
The scope of this review is to provide a state-of-the-art roadmap
of staphylococcal secretomes, which include both protein trans-
port pathways and the extracytoplasmic proteins of staphylococ-
cal organisms. The focus is on S. aureus, but comparisons with
Staphylococcus epidermidis and the best-characterized gram-pos-
itive bacterium, Bacillus subtilis, are included where appropriate.
Importantly, the present review aims to integrate the results of
genomic and proteomic studies on S. aureus secretomes, repre-
senting the first documented “comparative secretomics” study.
Specifically, this review deals with known and predicted exported
virulence factors, pathways for protein transport, signals for
subcellular protein sorting or secretion, and the exoproteomes
of different S. aureus isolates, as defined by two-dimensional
polyacrylamide gel electrophoresis (2D-PAGE) and mass
spectrometry (Fig. 2 and 3). The exoproteome is defined by all
S. aureus proteins that can be identified in the extracellular
milieu of this organism and thus includes proteins actively
secreted by living cells and the remains of dead cells. For a
clear appreciation of the present review, it is important to bear
in mind that the proteins exported from the cytoplasm could be
directly involved in staphylococcal virulence, whereas the re-
spective protein export systems represent the “pathways to
pathogenesis.”
EXPORTED STAPHYLOCOCCAL VIRULENCE FACTORS
S. aureus and S. epidermidis are organisms that occur naturally
in and on the human body. While S. epidermidis is mostly present
on human skin, S. aureus can be found on mucosal surfaces. S.
aureus is carried by 30 to 40% of the population (143) and can be
identified readily in the nose, but the organism can also be de-
tected in other moist regions of the human body, such as the
axillae, perineum, vagina, and rectum, which thereby form a ma-
jor reservoir for infections. Although most staphylococcal infec-
tions are nosocomial (i.e., hospital acquired), an increase in the
FIG. 1. Imaging of S. aureus RN6390. (A) For scanning electron mi-
croscopy, a drop of washed culture of bacteria was fixated for 30 min with
2% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.38. Next, the fixated
bacteria were placed on a piece (1 cm2) of cleaved 0.1% poly-L-lysine-
coated mica sheet and washed in 0.1 M cacodylate buffer. This specimen
was dehydrated in an ethanol series consisting of 30%, 50%, 70%, 96%,
and anhydrous 100% (3) solutions for 10 min each, critical point dried
with CO2, and sputter coated with 2 to 3 nm Au/Pd (Balzers coater). The
specimen was fixed on a scanning electron microscope stub holder and
observed in a JEOL FE-SEM 6301F microscope. (B) Micrograph of a
cluster of S. aureus cells grown in blood culture medium. The cells were
fixed with ethanol and hybridized with the fluorescein-labeled peptide
nucleic acid (PNA) probe PNA-Stau. The image was generated by merg-
ing an epifluorescence image with the negative of a phase-contrast image.
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number of cases of community-acquired, antibiotic (methicillin)-
resistant infections is currently being observed worldwide (27, 67,
185). The risk of intravascular and systemic infection by S. aureus
rises when the epithelial barrier is disrupted by intravascular cath-
eters, implants, mucosal damage, or trauma. Interestingly, after
infection, cells of S. aureus can persist unnoticed in the human
body for a long time (years), after which they can suddenly cause
another infection. S. aureus is primarily an extracellular pathogen
whose colonization and invasion of human tissues and organs can
lead to severe cytotoxic effects. Nevertheless, S. aureus can also be
internalized by various cells, including nonphagocytic cells, which
seems to induce apoptosis (43, 72, 120). Although S. aureus has
the potential to form biofilms (64), S. epidermidis infections are
particularly notorious for the formation of thick multilayered bio-
films on indwelling catheters and other implanted devices. The
formation of such a biofilm takes place in several steps, during
which the bacteria first adhere rapidly to the surface of a polymer
material that has been coated with a film of proteinaceous and
nonproteinaceous organic host molecules (56). Bacteria that ad-
here to this film produce extracellular polymeric substances,
mostly polysaccharides and proteins, in turn resulting in a strong
attachment to the polymer surface and other bacteria in the
growing biofilm. Ultimately, the biofilm is composed of multiple
layers of cells, cellular debris, polysaccharides, and proteins. S.
epidermidis factors that are essential for biofilm formation include
the polysaccharide intercellular adhesin (107), the accumulation-
associated protein (157), and the biofilm-associated protein (184).
Polysaccharide intercellular adhesin is most likely identical to the
polysaccharide adhesion protein.
Virulence of S. aureus
The pathogenicity of S. aureus is caused by the expression of
an arsenal of virulence factors (Table 1), which can lead to
superficial skin lesions, such as styes, furunculosis, and paro-
nychia, or to more serious infections, such as pneumonia, mas-
titis, urinary tract infections, osteomyelitis, endocarditis, and
even sepsis. In very rare cases, S. aureus causes meningitis. The
FIG. 2. Extracellular proteomes of different S. aureus strains. Proteins in the growth medium fractions of different staphylococcal isolates,
grown in TSB medium (37°C) to an optical density at 540 nm (OD540) of 10, were separated by 2D-PAGE using immobilized pH gradient strips
in the pH range of 3 to 10 (Amersham Pharmacia Biotech, Piscataway, N.J.). Each gel was loaded with 350 g protein extracts and, after
electrophoresis, stained with colloidal Coomassie blue. Proteins were identified by matrix-assisted laser desorption ionization–time of flight mass
spectrometry. The corresponding protein spots are labeled with protein names according to the S. aureus N315 database or NCBI entries for
proteins not present in N315. The S. aureus strains that were used in these experiments are RN6390 and COL and four clinical isolates from the
University Medical Center Groningen, named MRSA693331, 035699y/bm, 0440579/rmo, and CA-MRSA021708m/rmo.
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virulence factors that S. aureus employs to cause these diseases
are displayed at the surface of the staphylococcal cell or se-
creted into the host milieu (57). Specifically, these virulence
factors include (i) surface proteins that promote adhesion to
and colonization of host tissues, (ii) invasins that are exported
to an extracytoplasmic location and promote bacterial spread
in tissues (leukocidin, kinases, and hyaluronidase), (iii) surface
factors that inhibit phagocytic engulfment (capsule and protein
A), (iv) biochemical properties that enhance staphylococcal
survival in phagocytes (carotenoid and catalase production),
(v) immunological disguises (protein A, coagulase, and clotting
factor), (vi) membrane-damaging toxins that disrupt eukary-
otic cell membranes (hemolysins and leukotoxin), (vii) super-
antigens that contribute to the symptoms of septic shock
(SEA-G, toxic shock syndrome toxin [TSST], and ET), and
(viii) determinants for inherent and acquired resistance to an-
timicrobial agents.
Most virulence factors are expressed in a coordinated fash-
ion during the growth cycle of S. aureus. The best-character-
ized regulators of virulence factors are the accessory gene
regulator (agr) (124, 144, 152) and the staphylococcal accessory
regulator (SarA) (29, 30). Ziebandt et al. (208) showed that
extracellular proteins can be divided into two groups based on
the timing of their expression in cells grown in tryptic soy broth
FIG. 3. Dynamics of the amount of extracellular proteins during growth of S. aureus RN6390 in TSB medium. (A) Individual dual-channel 2D
patterns of extracellular proteins during the different phases of the growth curve for cells grown in TSB medium were assembled into a movie. The
protein pattern at an OD540 of 1 (labeled in green) was compared with the protein patterns at higher optical densities (labeled in red). As a
consequence of dual channel labeling, spots where the intensities do not differ between the compared gels are yellow, and spots with different
intensities are either green or red (15). (B) Growth curve for S. aureus RN6390 grown in TSB medium, as determined by OD540 readings. The
sampling points for proteomics analyses are indicated by arrows. (C) Proteomic signatures of selected proteins representing different regulatory
groups, as revealed by dual-channel imaging. The amounts of the respective proteins at an OD540 of 1 (spots labeled in green) for cells grown in
TSB medium were compared with the relative amounts of these proteins at higher optical densities (spots labeled in red). Proteins were stained
with Sypro ruby.
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(TSB), i.e., proteins that are expressed only at low cell densities
and proteins exclusively expressed at high cell densities. agr
seems to be an important positive regulator of proteins that are
expressed at higher optical densities (e.g., proteases, hemo-
lysins, and lipases) and a negative regulator of proteins that are
expressed during the exponential growth phase (e.g., immuno-
dominant antigen A, secretory antigen precursor, and several
proteins with unknown functions). In addition, Gill et al. (63)
identified 15 other two-component regulatory systems in the
genomes of S. aureus and S. epidermidis that are potentially
involved in staphylococcal virulence. In this respect, it is inter-
esting that the antibiotic cerulenin, which is known to inhibit
protein secretion by S. aureus at sub-MIC levels, was recently
reported to block the transcriptional activation of at least two
regulatory determinants, agr and sae. Thus, it seems that ceru-
lenin inhibits the transcription of genes for secretory proteins
rather than the secretion process of these proteins (1). In
contrast, it was previously believed that cerulenin would inter-
fere with membrane function through an inhibition of normal
fatty acid synthesis.
Notably, to date, relatively little information is available on
the molecular nature of the stimuli that are perceived by the
major regulators of the expression of virulence factors. Overall,
it should be clear that strain-specific differences in gene regu-
lation by agr, sae, sarA, or other regulators may dramatically
influence the repertoire of produced virulence factors, thereby
having a profound impact on the disease-causing potential of
different strains. Since the interplay of different regulators and
cell-to-cell communication can impact differently on the ex-
pression of different virulence factors, even the disease-causing
potential of individual S. aureus cells within a genetically iden-
tical population may vary.
Resistance of S. aureus to Antibiotics
Resistance of S. aureus to antibiotics was observed very soon
after the introduction of penicillin about 60 years ago. In the
following years, the amazing ability of staphylococci to develop
resistance to antibiotics has resulted in the emergence of meth-
icillin-resistant S. aureus (MRSA) and S. epidermidis strains. In
fact, methicillin resistance was observed already in 1961 in
nosocomial isolates of S. aureus, 1 year after the introduction
of methicillin (85). Resistance towards methicillin is a result of
the production of an altered penicillin binding protein, PBP2a
(or PBP2), which has less affinity for most -lactam antibiot-
ics. The PBP2a protein, which is located at the membrane-cell
wall interface, is of major importance for cell wall biogenesis
by mediating the cross-linking of peptidoglycans. PBP2a is
encoded by the mecA gene, which is located on a mobile
genetic element known as the staphylococcal cassette chromo-
some mec element (SCCmec) (28, 84). SCCmec is a basic
mobile genetic element that serves as a vehicle for gene ex-
change among staphylococcal species (49). In addition to the
mecA gene, SCCmec carries the mecA regulatory genes mecI
and mecR, an insertion sequence element (IS431mec), and a
unique cassette of recombinase genes (ccr), which are respon-
sible for SCCmec chromosomal integration and excision. Five
different types of SCCmec elements, types I to V, have been
identified so far, based on the classes of mecA gene and ccr
gene complexes (84). The type I SCCmec contains the mecA
gene as the only resistance element, while the type II and III
elements contain, besides mecA, multiple determinants for re-
sistance against non--lactam antibiotics. Accordingly, type II
and III SCCmec elements are responsible for multidrug resis-
tance in nosocomial MRSA isolates. Type IV SCCmec ele-
ments, like type I elements, contain no resistance genes other
than mecA, and they are significantly smaller than the type II
and III elements. This might serve as an evolutionary advan-
tage, making it easier for these mobile genetic elements to
spread across bacterial populations. Type V SCCmec elements
are also small compared to the other elements and differ in
their set of recombinase genes (84). Whereas the type I to IV
SSCmec elements contain the two recombinase genes ccrA and
ccrB, the type V elements contain a single copy of a gene, ccrC,
homologous to a cassette chromosome recombinase gene. In
addition, two open reading frames, hsdS and hsdM, which
encode a restriction-modification system, are unique to these
elements. Phylogenetic analyses of these genes showed a dis-
tant relationship with their homologues in other S. aureus
genomes and suggested a foreign origin for these genes.
Vancomycin resistance was first reported for Enterococcus
faecium (101), and transfer of vancomycin resistance from en-
terococci, such as Enterococcus faecalis, to S. aureus has been
shown to occur (137). Vancomycin has long been a last-resort
antibiotic for multiple-drug-resistant S. aureus strains, but al-
ready in 1996 a strain was isolated which showed reduced
sensitivity towards vancomycin (78). Shortly afterwards, addi-
tional strains were isolated in different countries and were
designated vancomycin intermediately resistant S. aureus
(VISA). These strains show a significantly thickened cell wall,
TABLE 1. Virulence factors of S. aureus
Pathogenic action Virulence factors Proteins or other compounds Functions References




35, 68, 93, 111, 114,
149, 155, 198




Geh, Hla, Hld, HlgA-C, HysA,






Inhibition of phagocytic engulfment Surface factors CapA-P, Efb, Spa Capsule, protein A 102, 196
Survival in phagocytes Biochemical compounds KatA, staphyloxanthin Carotenoids, catalase production 96, 109
Immunological disguise and
modulation
Surface proteins ClfA, ClfB, Coa, Spa Clumping factor, coagulase,
protein A
141, 142, 191
Contribution to symptoms of septic
shock





Resistance proteins BlaZ, MecA, VanA Methicillin and vancomycin
resistance
28, 85, 199
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which allows them to sequester more vancomycin than non-
VISA strains, thereby preventing the detrimental effects of this
antibiotic (42). A search for the genetic basis of the lowered
vancomycin sensitivity of the S. aureus Mu50 strain revealed
that important genes for cell wall biosynthesis and intermedi-
ary metabolism have mutations compared to those in MRSA
strains, which might lead to altered expression of genes in-
volved in cell wall metabolism and a thickened cell wall (4).
The first highly-vancomycin-resistant strain was isolated in
2002 (199). This strain was shown to carry a plasmid which
contains, among other resistance genes, the vanA gene plus
several additional genes required for vancomycin resistance.
The proteins encoded by these genes are responsible for re-
placing the C-terminal D-alanyl–D-alanine (D-Ala–D-Ala) of
the disaccharide pentapeptide cell wall precursor with a depsi-
peptide, D-alanyl–D-lactate (D-Ala–D-Lac), thereby lowering
the cell wall affinity for vancomycin (24).
Export of Virulence Factors from the Cytoplasm
Since most proteinaceous virulence factors are displayed at
the surface of the staphylococcal cell or released into the
medium, it is important for our understanding of the patho-
genic potential of these organisms to map their pathways for
protein transport. While specific questions relating to surface
display or secretion of particular virulence factors have been
addressed for several years, more holistic studies on the
genomics and proteomics of these processes have been docu-
mented in the scientific literature only very recently. Moreover,
no systematic analysis of pathways and cellular machinery for
protein transport has thus far been performed for staphylo-
cocci. This review is aimed at filling this knowledge gap. To do
so, we have taken full advantage of the availability of six com-
pletely sequenced and annotated S. aureus genomes and one of
the two sequenced S. epidermidis strains as well as recently
published data on the analysis of staphylococcal cell wall pro-
teomes and exoproteomes. Additionally, we have combined
published information with bioinformatics-derived data on all
potential signals for protein export from the cytoplasm and
secretion into the extracellular milieu or retention in the mem-
brane or cell wall. Since polytopic membrane proteins do not
appear to have major direct roles in virulence other than caus-
ing drug resistance, such membrane proteins remain beyond
the scope of this review. Furthermore, since the secretome of
B. subtilis has been characterized extensively, at the level of
both the protein export machinery and the exoproteome, we
have compared the staphylococcal secretomes with that of B.
subtilis. To our knowledge, this has resulted in the first “com-
parative secretomics” study.
S. AUREUS STRAINS SUITABLE FOR
COMPARATIVE SECRETOMICS
Nine sequenced and fully annotated genomes of S. aureus
are available in public databases (Table 2) (http://www.ncbi
.nlm.nih.gov/genomes/lproks.cgi; http://www.tigr.org), and six
of these genomes were used in the present study. These include
the genome of one of the first hospital-acquired MRSA iso-
lates, S. aureus COL (63), which has been used widely in
research on staphylococcal methicillin and vancomycin resis-
tance. The sequenced MRSA252 strain (79) is a hospital-ac-
quired epidemic strain, which was isolated from a patient who
died as a consequence of septicemia. The sequenced MSSA476
strain (79) is a community-acquired invasive strain that is pen-
icillin and fusidic acid resistant but susceptible to most com-
monly used antibiotics. S. aureus Mu50 and N315 (100) are
hospital-acquired MRSA strains isolated from Japanese pa-
tients. In addition, the Mu50 strain displays intermediate van-
comycin sensitivity. Finally, the community-acquired isolate S.
aureus MW2 (7) is a highly virulent MRSA strain isolated from
a 16-month-old girl from the United States. Notably, the most
widely used laboratory strain, NCTC8325, has been sequenced,
but the nucleotide sequence and corresponding annotation
were not available for the present analyses. This was also the
case for the community-acquired MRSA strain USA300 (46).
Furthermore, the sequence of S. aureus RF122, a strain asso-
ciated with mastitis in cattle, is now also available in the NCBI
database (unpublished), but it was not included in the present
review, which is primarily focused on staphylococcal pathoge-
nicity towards humans. Using multilocus sequence typing with
seven housekeeping genes of the different S. aureus strains,
Holden et al. (79) showed that the MRSA252 strain is phylo-
genetically most distantly related to the other sequenced
strains, while the Mu50 and N315 strains are indistinguishable
by multilocus sequence typing, as are the MSSA476 and MW2
strains. The COL and NCTC8325 strains are relatively closely
related to each other.
Sequenced and annotated genomes of other staphylococcal
species, such as S. epidermidis, Staphylococcus haemolyticus, and
Staphylococcus carnosus, are also publicly available. How-
TABLE 2. Sequenced and annotated genomes of S. aureus strains
Strain Origina
Genome size (kbp) No. of protein-encoding genes
Chromosome Plasmid Chromosome Plasmid
COL Hospital-acquired MRSA 2,809 4 2,615 3
MRSA252 Hospital-acquired MRSA 2,903 2,656
MSSA476 Community-acquired MSSA 2,800 21 2,579 19
Mu50 Hospital-acquired VISA 2,879 25 2,697 34
MW2 Community-acquired MRSA 2,820 2,632
N315 Hospital-acquired MRSA 2,815 25 2,588 31
NCTC8325 Hospital-acquired MSSA 2,821 2,892
USA300 Community-acquired MRSA 2,873 45 2,560 44
RF122 Bovine mastitis isolate 2,743 2,515
a MSSA, methicillin-sensitive S. aureus.
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ever, with the exception of S. epidermidis strain ATCC 12228
(207), these are not included in the present review, which
focuses primarily on S. aureus. A comparative genomic anal-
ysis of S. aureus COL, Mu50, MW2, and N315 and the
sequenced S. epidermidis strains RP62a and ATCC 12228
revealed that these species and strains have a set of 1,681
genes in common (63). In contrast, 454 genes are present in
the S. aureus strains but not in S. epidermidis, whereas 286
genes are present in S. epidermidis but not in S. aureus. Most
of the strain-specific and species-specific genes can be re-




The bacterial machinery for protein transport is currently
best described for Escherichia coli (gram negative) and B. sub-
tilis (gram positive) (for reviews, see references 44, 174, and
175). Many of the known components that are involved in the
different routes for protein export from the cytoplasm and in
posttranslocational modification of exported proteins in these
organisms are also conserved in S. aureus and S. epidermidis
(Table 3). In general, proteins that are exported are synthe-
sized with an N-terminal signal peptide, which directs them to
a particular transport pathway. Consequently, the presently
known signal peptides are classified according to the export
pathway into which they direct the corresponding proteins or
the type of signal peptidase that is responsible for their re-
moval (processing) upon membrane translocation. The staph-
ylococcal protein export pathways that have been character-
ized experimentally or that can be deduced from sequenced
genomes are shown schematically in Fig. 4 and are discussed
below. Since these pathways are likely used for the export of
virulence factors to the cell surface and the milieu of the host,
TABLE 3. Secretion machinery of S. aureus, S. epidermidis, and B. subtilis a
Pathway and component Protein(s)
Presence of protein
S. aureus S. epidermidis B. subtilis
Sec pathway
Chaperone Ffh   
FtsY   
FlhF   
CsaA   
Translocation motor SecA1   
SecA2   
Translocation channel SecY1   
SecY2   
SecE   
SecG   
SecDF   
YajC (YrbF)   
Lipid modification Lgt   
Signal peptidase SpsA (inactive)   
SpsB (SipSTUV)  b 
SipW (ER-type)   
LspA  c 
Folding catalyst PrsA   
BdbC   
DsbA (BdbD)   
Tat pathway
Translocase TatA   
TatC   
Pseudopilin pathway ComGA   
ComGB   
ComC   
Bacteriocins Bacteriocin-specific ABC transporters Unknown Unknown 
Holins CidA (holin)   
LrgA (anitholin)   
ESAT-6 pathway EsaA   
EsaB   
EsaC d   
EssA   
EssB   
EssC   
a Based on BLAST searches with the corresponding proteins of B. subtilis in the finished genome database (http://www.ncbi.nlm.nih.gov/sutils/genom_table.cgi).
b Two potentially active type I SPases are present in this strain and share homology with B. subtilis SipS and SipU.
c Two LspA proteins are present in this strain.
d This protein is missing in the S. aureus MRSA252 strain.
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Fig. 4 can be regarded as a subcellular road map to staphylo-
coccal pathogenesis.
Components of the Sec Pathway
The most commonly used pathway for bacterial protein
transport is the general secretory (Sec) pathway. Specifically,
this pathway is responsible for the secretion of the majority of
the proteins found in the exoproteome of B. subtilis, which is
probably also the case for most other gram-positive bacteria,
including S. aureus (174). Unfortunately, there are very few
published data available concerning the Sec pathway of S.
aureus, and therefore we have filled in the current knowledge
gaps with data obtained from studies of B. subtilis or E. coli.
Proteins that are exported via the Sec pathway contain signal
peptides with recognition sites for so-called type I or type II
SPases. Notably, type II SPase recognition sites overlap with
the recognition sites for the diacylglyceryl transferase Lgt. Pre-
cursor proteins with a type II SPase recognition sequence are
lipid modified prior to being processed, and the resulting ma-
ture proteins are retained as lipopoteins in the cytoplasmic
membrane via their diacylglyceryl moieties. Furthermore, the
Sec-dependent export of proteins can be divided into the fol-
lowing three stages: (i) targeting to the membrane transloca-
tion machinery by export-specific or general chaperones, (ii)
translocation across the membrane by the Sec machinery, and
(iii) posttranslocational folding and modification. If the trans-
located proteins of gram-positive bacteria lack specific reten-
tion signals for the membrane or cell wall, they are secreted
into the growth medium.
Preprotein targeting to the membrane. In B. subtilis, the only
known secretion-specific chaperone is the signal recognition
particle (SRP), which consists of small cytoplasmic RNA
(scRNA), the histone-like protein HBsU, and the Ffh protein.
Ffh and HBsU bind to different moieties of the scRNA. Stud-
ies with E. coli have shown that upon emergence from the
ribosome, the signal peptide of a nascent secretory protein can
be recognized by several cytoplasmic chaperones and/or tar-
geting factors, such as Ffh or trigger factor (TF) (55). In con-
trast to Ffh, which is required for cotranslational protein ex-
port in E. coli, the cytoplasmic chaperone SecB has mainly
been implicated in posttranslational protein targeting. Notably,
FIG. 4. Staphylococcal pathways to pathogenesis. The figure shows a schematic representation of a staphylococcal cell with potential pathways
for protein sorting and secretion. (A) Proteins without signal peptides reside in the cytoplasm. (B) Proteins with one or more transmembrane-
spanning domains can be inserted into the membrane via the Sec, Tat, or Com pathway. (C) Lipoproteins are exported via the Sec pathway and
are anchored to the membrane after lipid modification. (D) Proteins with cell wall retention signals are exported via the Sec, Tat, or Com pathway
and retained in the cell wall via covalent or high-affinity binding to cell wall components. (E) Exported proteins with a signal peptide and without
a membrane or cell wall retention signal can be secreted into the extracellular milieu via the various indicated pathways.
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however, SecB is absent from the sequenced gram-positive
bacteria, including S. aureus and B. subtilis. Most likely, ribo-
some-nascent chain complexes of S. aureus are thus targeted to
the membrane by SRP, which, by analogy to the case in B.
subtilis and E. coli, will probably involve the SRP receptor
FtsY. At the membrane, the nascent preprotein will be di-
rected to the translocation machinery. This process is likely
stimulated by negatively charged phospholipids (45), the Sec
translocon (17, 45), and/or the SecA protein (25). In this re-
spect, SecA may function not only as the translocation motor
(see below) but also as a chaperone for preprotein targeting
(75). While it has been shown that Ffh is essential for growth
and viability in E. coli and B. subtilis, this does not seem to be
the case for all bacteria. For example, Ffh, FtsY, and scRNA
are not essential in Streptococcus mutans. In this organism, the
SRP is merely required for growth under stressful conditions,
such as low pH (pH 5), high salt (3.5% NaCl), or the pres-
ence of H2O2 (0.3 mM). This suggests that SRP has an impor-
tant role in the export of proteins to the membrane or cell wall
to protect S. mutans against environmental insults (71).
For B. subtilis, it has been proposed that the general chap-
erone CsaA may have a role in preprotein targeting to the
membrane, similar to SecB of E. coli. This view is supported by
the observation that the B. subtilis CsaA protein has binding
affinity for SecA and preproteins (126). However, CsaA is not
conserved in S. aureus. Therefore, it remains to be investigated
whether other chaperones with a preprotein targeting function
are present in S. aureus.
Translocation across the membrane. As deduced from
known genome sequences, the translocation machinery of S.
aureus consists of several Sec proteins. The mode of action of
these proteins has been studied in great detail in E. coli (44,
197). After binding of a preprotein to a SecA dimer, the SecA
molecules will bind ATP, resulting in conformational changes
that promote their insertion together with the preprotein into
the membrane-embedded translocation channel. Subsequent
hydrolysis of ATP causes SecA to release the preprotein, re-
turn to its original conformation, and deinsert from the trans-
location channel. Repeated cycles of ATP binding and hydro-
lysis by SecA, together with the proton motive force, drive
further translocation of the preprotein across the membrane.
The translocation channel is essentially formed by the SecE
and SecY proteins, which are conserved in all bacteria (189).
An additional nonessential channel component is SecG, which
serves to increase the translocation efficiency. While the SecY
proteins of different bacteria show a relatively high degree of
sequence similarity, the SecE and SecG proteins, though
present in all bacteria, are less well conserved. Specifically, the
SecE and SecG proteins in B. subtilis, S. aureus, and S. epider-
midis are considerably shorter than the equivalent proteins of
E. coli. Although SecA and SecY of S. aureus (referred to here
as SecA1 and SecY1) have not yet been characterized func-
tionally, they are of major importance for the growth of S.
aureus. This was demonstrated with the help of specific anti-
sense RNAs (86). Upon secA antisense induction, a strong
growth defect was observed, and secY antisense induction
turned out to be lethal.
Remarkably, the genome of S. aureus contains a second set
of secA and secY genes, referred to as secA2 and secY2, respec-
tively. In contrast to the SecA1 and SecY1 proteins, their
homologues are not essential for growth and viability. It is
presently unknown whether SecA2 and SecY2 transport spe-
cific proteins across the membrane of S. aureus. However, it
has been shown for other pathogenic gram-positive bacteria
which also possess a second set of SecA and SecY proteins that
these proteins are required for the transport of certain proteins
related to virulence. In Streptococcus gordonii, the export of
GspB, a large cell surface glycoprotein that contributes to
platelet binding, seems to be dependent on the presence of
SecA2 and SecY2 (13). This protein contains large serine-rich
repeats, an LPXTG motif for cell wall anchoring (see below),
and a very large signal peptide of 90 amino acids. In Strepto-
coccus parasanguis, two other proteins, FimA and Fap1, are
known to be secreted via SecA2-dependent membrane trans-
location. FimA is a (predicted) lipoprotein which is a major
virulence factor implicated in streptococcal endocarditis. The
FimA homologue in S. aureus is a manganese-binding lipopro-
tein (MntA) associated with an ATP-binding cassette (ABC)
transporter. Fap1 of S. parasanguis is involved in adhesion to
the surfaces of teeth. Like FimA, Fap1 has a long signal pep-
tide of 50 amino acids, serine-rich repeats, and an LPXTG
motif for cell wall anchoring. To date, it is not known what
determines the difference in specificity of the SecA1/SecY1
and SecA2/SecY2 translocases. It is also not known whether
the SecA2/SecY2 translocase shares SecE and/or SecG with
the SecA1/SecY1 translocase, whether these translocases func-
tion completely independently from each other, or whether
mixed translocases can occur. Clearly, the secE and secG genes
are not duplicated in S. aureus. The SecE and SecG functions
in the SecA2/SecY2 translocase may, however, be performed
by the S. aureus homologues of the Asp4 and Asp5 proteins of
S. gordonii, for which SecE- and SecG-like functions have been
proposed (172).
In E. coli, the heterotrimeric SecYEG complex is associated
with another heterotrimeric complex composed of the SecD,
SecF, and YajC proteins (138). This complex has been shown
to be involved in the cycling of SecA (51) and the release of the
translocated protein from the translocation channel (113).
SecD and SecF are separate but structurally related proteins in
most bacteria, including E. coli. Interestingly, in B. subtilis and
S. aureus, natural gene fusions between the secD and secF
genes are observed. Accordingly, the corresponding SecDF
proteins can be regarded as molecular “Siamese twins” (20).
Unlike SecA, SecY, and SecE, the SecDF protein of B. subtilis
is not essential for growth and viability, and its role in protein
secretion is presently poorly understood (20). B. subtilis secDF
mutants showed only a mild secretion defect under conditions
of high-level synthesis of secretory proteins. The known SecDF
proteins have 12 (predicted) transmembrane domains with two
large extracytoplasmic loops, between the first and second
transmembrane segments and between the seventh and eighth
transmembrane segments. For E. coli SecD, it has been shown
that small deletions in the large extracytoplasmic loop result in
malfunctioning of the protein, while the stability of the SecDF-
YajC complex is not affected (138). It has therefore been
proposed that this loop in SecD might provide a protective
structure in which translocated proteins can fold more effi-
ciently. The large extracytoplasmic loop in SecF has been pro-
posed to interact with SecY, thereby stabilizing the transloca-
tion channel formed by SecYEG. Homologues of the E. coli
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YajC protein are present in many bacteria, including S. aureus
and B. subtilis (YrbF), but their role in protein secretion has
not yet been established. It is presently not known whether the
S. aureus SecDF-YajC complex associates specifically with the
SecA1/SecY1 translocase, the SecA2/SecY2 translocase, or
both.
Type I signal peptidases. Signal peptides of preproteins are
cleaved during or shortly after translocation by an SPase I or
SPase II, depending on the nature of the signal peptide (180,
187). The B. subtilis chromosome encodes five type I SPases,
named SipS, SipT, SipU, SipV, and SipW (176, 178, 186). Two
of these, SipS and SipT, are of major importance for the
processing of secretory preproteins, growth, and viability. In S.
aureus, only two SPase I homologues are present, namely,
SpsA and SpsB. The catalytically active SPase I in S. aureus is
SpsB, which is probably essential for growth and viability (38).
This SPase can be used to complement an E. coli strain that is
temperature sensitive for preprotein processing. In general,
type I SPases recognize residues at the 1 and 3 positions
relative to the cleavage site (187). For B. subtilis, it has been
shown that all secretory proteins identified by proteomics have
Ala at the1 position and that 71% of these secretory proteins
have Ala at the 3 position (174). In contrast, various residues
are tolerated at the 2 position, including Ser, Lys, Glu, His,
Tyr, Gln, Gly, Phe, Leu, Ala, Asp, Asn, Trp, and Pro. Inter-
estingly, Bruton et al. (23) studied the cleavage sites in sub-
strates of S. aureus SpsB and showed that this enzyme has a
preference for basic residues at the 2 position and tolerance
for hydrophobic residues at this position. However, an acidic
residue at the 2 position resulted in a significantly reduced
rate of processing. The second SPase I homologue of S. aureus
(SpsA) appears to be inactive, since it lacks the catalytic Ser
and Lys residues, which are replaced with Asp and Ser resi-
dues, respectively. The presence of an apparently catalytically
inactive SpsA homologue is a conserved feature of all staphy-
lococci with sequenced genomes. Notably, in addition to an
inactive SpsA homologue, S. epidermidis contains two SpsB
homologues, which show the greatest similarity to SipS and
SipU of B. subtilis. To date, it is not known whether the inactive
SpsA homologues contribute somehow to protein secretion in
these organisms.
Lipid modification of lipoproteins. In E. coli, lipid modifi-
cation of prolipoproteins involves three sequential steps that
are catalyzed by cytoplasmic membrane-bound proteins. The
first step involves the transfer of a diacylglyceryl group from
phosphatidylglycerol to the sulfhydryl group of the invariant
Cys residue present at the 1 position of the signal peptide
cleavage site in lipoprotein precursors. This step is catalyzed by
a phosphatidyl glycerol diacylglyceryl transferase (Lgt), as
shown for E. coli by Sankaran and Wu (161). The recognition
sequence for Lgt, which includes the Cys residue that becomes
modified with diacylglyceryl, is known as the lipobox. Lipid
modification of the lipobox Cys residue is necessary for the
lipoprotein-specific type II signal peptidase (LspA) to recog-
nize and cleave the signal peptide of a prolipoprotein, which
represents the second step in lipoprotein modification. The
third step involves the transfer of an N-acyl group by an N-acyl
transferase (Lnt), resulting in the formation of N-acyl diacyl-
glycerylcysteine at the N terminus of the mature lipoprotein.
Although Lgt and LspA are present in most, if not all, bacteria,
Lnt is present only in gram-negative bacteria (180). Like the
case for other gram-positive bacteria, no homologue of Lnt
could be detected in the genomes of S. aureus or S. epidermidis
(169), which suggests that the lipoproteins of these organisms
are not N acylated.
S. aureus Lgt is a protein of 279 amino acids that contains a
highly conserved HGGLIG motif (residues 97 to 102). Al-
though the His residue in this motif was shown to be essential
for the catalytic activity of E. coli Lgt (160), it is not strictly
conserved in all known Lgt proteins. On the other hand, the
strictly conserved Gly at position 103 of E. coli Lgt, which is
equivalent to Gly98 of S. aureus Lgt, is required for the activity
of this protein. Stoll et al. (169) showed that an S. aureus lgt
mutation has no effect on growth in broth, as also observed for
B. subtilis (104). Nevertheless, the absence of Lgt has a con-
siderable effect on the induction of an inflammatory response.
Importantly, lipid modification serves to retain exported pro-
teins at the membrane-cell wall interface. This is particularly
relevant for gram-positive bacteria, which lack an outer mem-
brane that represents a retention barrier for exported proteins.
In the absence of Lgt, B. subtilis cells release a variety of
lipoproteins into the extracellular milieu, in the form of both
unmodified precursor proteins and alternatively processed ma-
ture proteins that lack the N-terminal Cys residue (3). Simi-
larly, the S. aureus lgt mutation resulted in the shedding of
certain abundant lipoproteins, such as OppA, PrsA, and SitC,
into the broth. These lipoproteins are normally retained in the
membrane or cell wall of S. aureus.
Type II signal peptidase. As described above, lipoprotein
signal peptides of prolipoproteins are cleaved by type II SPases
after the Cys residue in the lipobox is modified by Lgt. Al-
though B. subtilis and many other bacteria contain only one
copy of the lspA gene, some organisms, such as S. epidermidis,
Bacillus licheniformis, and Listeria monocytogenes, contain a
second copy. LspA is a membrane protein that spans the mem-
brane four times, and both its N and C termini face the cyto-
plasmic side of the membrane (178, 188). Six amino acid res-
idues are important for SPase II activity, of which two Asp
residues form the active site (178). While processing of lipo-
proteins by LspA is essential for growth and viability for E. coli
and other gram-negative bacteria (202), it is not essential for B.
subtilis (177) and other gram-positive bacteria, such as Lacto-
coccus lactis (190). This suggests that processing of prolipopro-
teins is not essential for their functionality. This view is sup-
ported by the fact that PrsA, a lipoprotein required for correct
folding of translocated proteins, is essential for viability of B.
subtilis (99). In the absence of LspA, some of the lipoproteins
of B. subtilis are processed in an alternative way by unidentified
proteases, and the activity of unprocessed lipoproteins in lspA
mutants is reduced. Also, in these B. subtilis mutants, secretion
of the nonlipoprotein AmyQ was severely reduced (177). This
reduction might be the consequence of a malfunction of un-
modified PrsA in AmyQ folding. Although most lspA mutants
have been studied in gram-negative bacteria and a few non-
pathogenic gram-positive bacteria (177, 190), Sander et al.
(159) showed a severely attenuated phenotype of lspA mutants
of the pathogen Mycobacterium tuberculosis, which implies an
important role for lipoprotein processing by LspA during in-
fection with M. tuberculosis. In S. aureus, both the lspA and lgt
genes are present as single copies in the genomes of all six
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sequenced strains. Interestingly, one of the two LspA homo-
logues in S. epidermidis (125 amino acids) is considerably
shorter than other known LspA proteins, including its large
paralogue (177 amino acids). This is mainly the result of an
additional N-terminal transmembrane domain in the large
LspA proteins. As a result, the short S. epidermidis LspA pro-
tein is predicted to have three membrane-spanning domains,
with the N terminus located on the outside of the cell, the C
terminus located on the inside of the cell, and the (putative)
active-site Asp residues located on the outer surface of the
cytoplasmic membrane.
Signal peptide peptidase. After translocation and processing
of the preproteins by signal peptidases, the signal peptides are
rapidly degraded by signal peptide peptidases (SPPases). In B.
subtilis, two SPPases, TepA and SppA, are known to be in-
volved in translocation and processing of preproteins (21).
While TepA is required for translocation and processing of
preproteins, SppA is required only for efficient processing of
preproteins. Remarkably, no homologues of SppA or TepA
were detectable by BLAST searches in the sequenced genomes
of S. aureus and S. epidermidis. As reported by Meima and van
Dijl (119), L. lactis contains a protein that shows limited sim-
ilarity to TepA of B. subtilis and ClpP of Caenorhabditis
elegans, suggesting that this protein might be an SPPase analog
in L. lactis. In S. aureus and S. epidermidis, this protein homo-
logue also seems to be present and is predicted to be a cyto-
plasmic membrane protein (our unpublished observations).
Folding catalysts (PrsA and BdbD). Proteins that are trans-
ported across the membrane in a Sec-dependent manner
emerge at the extracytoplasmic membrane surface in an un-
folded state. These proteins need to be rapidly and correctly
folded into their native and protease-resistant conformation
before they are degraded by proteases in the cell wall or ex-
tracellular environment (162). An important folding catalyst in
B. subtilis is PrsA, which shows homology to peptidyl-prolyl
cis/trans-isomerases. PrsA is a lipoprotein (see “Lipoproteins”
below) that is essential for efficient protein secretion and cell
viability in B. subtilis (99, 162). Studies on the effects of PrsA
depletion showed that the relative amounts of extracellular
proteins from PrsA-depleted cells were significantly reduced
(192). No data have been published on S. aureus mutants
lacking PrsA, and it will be interesting to investigate whether
PrsA is also essential for the viability and virulence of this
organism. It has already been shown that S. aureus lacking Lgt
releases an increased amount of PrsA into the extracellular
milieu (169), which might indicate that (most) pre-PrsA is not
fully functional but is sufficient for viability. The observation by
Stoll et al. (169) also shows that, like the case in B. subtilis (3),
unmodified pre-PrsA is not effectively retained in the cytoplas-
mic membrane.
Other proteins that are involved in proper folding of extra-
cellular proteins in B. subtilis are the membrane proteins BdbC
and BdbD, which are involved in the formation of disulfide
bonds. Both proteins have been shown to be necessary for
stabilization of the membrane- and cell wall-associated pseudo-
pilin ComGC (118). This protein, which is required for DNA
binding and uptake during natural competence, contains an
intramolecular disulfide bond (31). Both BdbC and BdbD are
also important for the folding of heterologously produced E.
coli PhoA, which contains two disulfide bonds, into an active
and protease-resistant conformation (21, 118). Although a ho-
mologue of BdbD (named DsbA) is present in S. aureus, there
is no homologue of BdbC in this organism. The same appears
to be true for S. epidermidis. Nevertheless, measurements of
the redox potential of purified DsbA indicated that this protein
can act as an oxidase, and this view was confirmed by comple-
mentation studies with a dsbA mutant strain of E. coli (53). The
absence of a BdbC homologue in the staphylococci is remark-
able, since B. subtilis BdbC and BdbD are jointly required for
the folding of ComGC and E. coli PhoA. Notably, all se-
quenced S. aureus genomes encode homologues of ComGC,
including the Cys residues that form the disulfide bond in B.
subtilis ComGC. This raises the question of whether ComGC
of S. aureus does indeed contain a disulfide bond and, if so,
which protein(s) is involved in the formation of this disulfide
bond. Notably, S. aureus DsbA was recently shown to be a
lipoprotein that does not seem to contribute to the virulence of
this organism, as tested in mouse and Caenorhabditis elegans
models (53). Furthermore, DsbA was shown to be dispensable
for -hemolysin activity, despite the fact that this protein con-
tains a disulfide bond, which is required for activity (54).
Therefore, the biological function of DsbA in staphylococci
remains to be elucidated.
Tat Pathway
The twin-arginine translocation (Tat) pathway exists in many
bacteria, archaea, and chloroplasts. This pathway was named
after the consensus double (twin) Arg residues that are present
in the signal peptide. The twin Arg residues are part of a motif
that directs proteins specifically into the Tat pathway. In con-
trast to the Sec machinery, where only unfolded proteins are
translocated across the membrane, the Tat machinery is capa-
ble of translocating folded proteins. In gram-negative bacteria,
streptomycetes, mycobacteria, and chloroplasts, an active Tat
pathway seems to require three core components, named
TatA, TatB, and TatC (14, 47, 125, 154, 204). In all gram-
positive bacteria except streptomycetes and Mycobacterium
smegmatis, the Tat pathway involves only TatA and TatC (47,
204). Recent studies with E. coli and chloroplasts have resulted
in a model that proposes key roles for TatB-TatC complexes in
signal peptide reception and for TatA-TatB-TatC complexes in
preprotein translocation (2, 36). Interestingly, certain muta-
tions in E. coli TatA have been shown to allow this protein to
compensate for the absence of TatB (18). This demonstrates
that TatA is intrinsically bifunctional, which is consistent with
the fact that most gram-positive bacteria lack TatB but have
TatA (90). In B. subtilis, two minimal TatA-TatC translocases
with distinct specificities are active (88). While the constitu-
tively expressed TatAy-TatCy translocase of B. subtilis is re-
quired for secretion of a protein with unknown function,
YwbN, the TatAd-TatCd translocase seems to be expressed
only under conditions of phosphate starvation for secretion of
the phosphodiesterase PhoD (175, 188). Most other gram-
positive bacteria that have tatA and tatC genes, including S.
aureus, appear to have only one TatA-TatC translocase. The
functionality of the S. aureus Tat translocase remains to be
demonstrated. In contrast to S. aureus, S. epidermidis seems to
lack a Tat pathway.
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Pseudopilin Export (Com) Pathway
In B. subtilis, four proteins, ComGC, ComGD, ComGE, and
ComGG, have been identified as having an N-terminal pseudo-
pilin-like signal peptide (174, 175). All four of these proteins
are involved in DNA binding and uptake and are localized in
the membrane and cell wall. It is thought that these proteins
form a pilus-like structure in the cell wall or modify the cell
wall to provide a passage for DNA uptake. Translocation to
the extracytoplasmic membrane surface is possible only when
these proteins are processed by the pseudopilin-specific SPase
ComC in B. subtilis (52). SPases of this type are bifunctional
and catalyze not only signal peptide cleavage but also methyl-
ation of the N terminus of the mature protein (170). Further-
more, export and functionality of the four ComG proteins
depend on the integral membrane protein ComGB and the
traffic ATPase ComGA, which is located at the cytoplasmic
side of the membrane (32, 69). Homologues of ComC,
ComGA, ComGB, and ComGC, but not ComGD, ComGE,
and ComGG, are present in the six sequenced S. aureus strains.
This suggests that the Com system of S. aureus is not involved
in DNA uptake but is part of another solute transport process.
ABC Transporters
Bacteriocins are peptides or proteins that inhibit the growth
of other bacteria. Most of the characterized bacteriocins can be
divided into several classes, depending on specific posttransla-
tional modifications, the presence and processing of particular
leader peptides, and the machinery for export from the cyto-
plasm. A well-described class of bacteriocins is formed by the
lantibiotics. Members of this class are composed of short pep-
tides that contain posttranslationally modified amino acids,
such as lanthionine and -methyllanthionine (117). The pro-
duction of bacteriocins in S. aureus has been described for
various strains. S. aureus C55 produces the two lantibiotics
C55 and C55 (129). These lantibiotics are both encoded by
a 32-kb plasmid, which is readily lost upon growth at elevated
temperatures. C55 and C55 showed antimicrobial activity
towards other S. aureus strains and Micrococcus luteus but not
towards S. epidermidis. Furthermore, the nonlantibiotics
BacR1 (40), aureocin A53 (134), and aureocin A70 (132, 133)
have been identified as bacteriocins with activity against a
broad range of bacteria. The genes for both aureocins are
located on a plasmid that is present in S. aureus strains
isolated from milk. By analogy with the well-described bac-
teriocin export machineries of other organisms (73, 145), it
can be anticipated that all of the aforementioned bacterio-
cins are exported to the external staphylococcal milieu by
dedicated ABC transporters. However, no experimental ev-
idence for this assumption has been published for S. aureus.
Notably, it has been demonstrated that secretion of the
lantibiotics epidermin and gallidermin of S. epidermidis
Tu¨3298 and Staphylococcus gallinarum, respectively, is facil-
itated by so-called one-component ABC transporters. Spe-
cifically, the ABC transporter GdmT has been implicated in
the transport of these lantibiotics (145).
Holins
Holins are dedicated export systems for peptidoglycan-de-
grading endolysins that have been implicated in the pro-
grammed cell death of bacteria. These exporters, which are
composed of homo-oligomeric complexes, can be subdivided
into two classes, depending on the number of transmembrane
segments. While class I holin subunits have three transmem-
brane segments, class II holin subunits have two transmem-
brane segments (206). In S. aureus, the lrg and cid operons are
involved in murein hydrolase activity and antibiotic tolerance
(66, 153). A disrupted lrg operon leads to an increase in murein
hydrolase activity and a decrease in penicillin tolerance, and a
disrupted cid operon leads to a decrease in murein hydrolase
activity and an increase in penicillin tolerance. It is still unclear
how the CidA and LrgA proteins are involved in these mech-
anisms, but these proteins display significant similarity to the
bacteriaphage holin protein family, suggesting that they have a
role in protein export. It has therefore been proposed that the
CidA and LrgA proteins act on murein hydrolase activity and
antibiotic tolerance in a manner analogous to that of holins
and antiholins, respectively (11, 153). Sequence similarity
searches showed that the genes for LrgA and CidA are con-
served in the six sequenced S. aureus strains as well as in S.
epidermidis and B. subtilis. Notably, none of the three holins of
B. subtilis were shown to be involved in the secretion of pro-
teins to the extracellular milieu (174, 200).
ESAT-6 Pathway
The ESAT-6 secretion pathway was first described for M.
tuberculosis. It has been proposed that at least two virulence
factors, ESAT-6 (early secreted antigen target, 6 kDa) and
CFP-10 (culture filtrate protein, 10 kDa), are secreted via this
pathway in a Sec-independent manner (16, 166). Since this
pathway was discovered in mycobacteria, it is also known as the
Snm pathway (secretion in mycobacteria) (37). The genes for
ESAT-6 and CFP-10 are located in conserved gene clusters,
which also encode proteins with domains that are conserved in
FtsK- and SpoIIIE-like transporters. These conserved FtsK/
SpoIIIE domains have been termed FSDs (26). In other gram-
positive bacteria, including S. aureus, B. subtilis, Bacillus
anthracis, Clostridium acetobutylicum, and L. monocytogenes,
homologues of ESAT-6 have been identified (140). The genes
for these ESAT-6 homologues are also found in gene clusters
that contain at least one gene for a membrane protein with an
FSD. In S. aureus, two proteins, named EsxA and EsxB, have
been identified that seem to be secreted via the ESAT-6 path-
way (26). The esxA and esxB genes are part of a cluster con-
taining six other genes for proteins that have been implicated
in the translocation of EsxA and EsxB. These include the EsaB
and EsaC proteins, with a predicted cytoplasmic location, as
well as the predicted membrane proteins EsaA, EssA, EssB,
and EssC, among which EssC contains an FSD. Mutations in
essA, essB, or essC result in a loss of EsxA and EsxB produc-
tion, which may be related to inhibition of the synthesis of
these proteins or their folding into a protease-resistant confor-
mation. All sequenced S. aureus strains contain this cluster of
esa, ess, and esx genes, but it seems to be absent from S.
epidermidis. Interestingly, the genes for EsxB and EsaC appear
766 SIBBALD ET AL. MICROBIOL. MOL. BIOL. REV.
 o
n









to be absent from the S. aureus MRSA252 strain. This implies
that the ESAT-6 machinery of this strain may be required for
the transport of only EsxA and perhaps a few other unidenti-
fied proteins. If so, EsaC would be dispensable for an active
ESAT-6 pathway and might be specifically involved in the
export of EsxB. Alternatively, the ESAT-6 pathway could be
inactive in the S. aureus MRSA252 strain due to the absence of
EsaC.
Lysis
Various studies have shown that certain proteins with typical
cytoplasmic functions and without known signals for protein
secretion can nevertheless be detected in the extracellular pro-
teomes of different bacteria (174). Notably, many of these
proteins, such as catalase, elongation factor G, enolase, glyc-
eraldehyde-3-phosphate dehydrogenase, GroEL, and superox-
ide dismutase, are among the most highly abundant cytoplas-
mic proteins. This makes it likely that they are detectable in the
extracellular proteome due to cell lysis. Perhaps such proteins
are more resistant to extracytoplasmic degradation than are
other proteins that are simultaneously released by lysis. How-
ever, the possibility that the extracellular localization of typical
cytoplasmic proteins is due to the activity of as yet unidentified
export pathways cannot be excluded. Clearly, until recently this
possibility did still apply for the EsxA and EsxB proteins, which
are now known to be exported via the ESAT-6 pathway. A
clear indication that the presence of certain “cytoplasmic” pro-
teins in the extracytoplasmic milieu of bacteria may relate to
specific export processes was provided by Boe¨l and coworkers
(19), who showed that 2-phosphoglycerate-dependent auto-
modification of enolase is necessary for its export from the
cytoplasm.
PROPERTIES OF STAPHYLOCOCCAL SIGNAL
PEPTIDES AND CELL RETENTION SIGNALS
Signal Peptides
All proteins that have to be transported from the cytoplasm
across the membrane to the extracytoplasmic compartments of
the cell, or the extracellular milieu, need to contain a specific
sorting signal for their distinction from resident proteins of the
cytoplasm. The known bacterial sorting signals for protein ex-
port from the cytoplasm are signal peptides (195). These signal
peptides can be classified by the transport and modification
pathways into which they direct proteins. Presently, four dif-
ferent bacterial signal peptides are recognized that share a
common architecture but differ in the details (Fig. 5). Two of
these direct proteins into the widely used Sec pathway, includ-
ing the secretory (Sec-type) signal peptides and the lipoprotein
signal peptides. Proteins with Sec-type or lipoprotein signal
peptides are processed by different SPases (type I and type II
SPases, respectively) and are targeted to different destinations.
In S. aureus, proteins with Sec-type signal peptides are pro-
cessed by the type I SPase SpsB and are targeted to the cell
wall or extracellular milieu. Proteins with a lipoprotein signal
peptide are lipid modified by Lgt prior to being processed by
the type II SPase LspA. In principle, these lipoproteins are
retained at the membrane-cell wall interface, but they can be
liberated from this compartment by proteolytic removal of the
N-terminal Cys that contains the diacylglyceryl moiety (3).
Proteins with twin-arginine (RR) signal peptides appear to be
processed by type I SPases, at least in B. subtilis, and are
targeted to the cell wall or extracellular milieu (174). Proteins
with a pseudopilin signal peptide are processed by the pseudo-
pilin signal peptidase ComC and most likely are localized to
the cytoplasmic membrane and the cell wall. Finally, bacte-
riocins contain a completely different sorting and modifica-
tion signal that is usually called the leader peptide. The
known leader peptides show no resemblance to the afore-
mentioned signal peptides. The export of bacteriocins via
ABC transporters results in their secretion into the extra-
cellular milieu (121, 164).
Sec-type, lipoprotein, and RR signal peptides contain three
distinguishable domains, the N, H, and C domains. The N-
terminal domain contains positively charged amino acids,
which are thought to interact with the secretion machinery
and/or negatively charged phospholipids in the membrane.
The H domain is formed by a stretch of hydrophobic amino
acids which facilitate membrane insertion. Helix-breaking res-
idues in the middle of the H domain may facilitate H domain
looping during membrane insertion and translocation of the
precursor protein. The subsequent unlooping of the H domain
would display the SPase recognition and cleavage site at the
extracytoplasmic membrane surface, where the catalytic do-
mains of type I and type II SPases are localized (187). Helix-
breaking residues just before the SPase recognition and cleav-
age site would facilitate precursor processing by SPase I or II.
In fact, these helix-breaking residues and the SPase cleavage
site, respectively, define the beginning and the end of the C
domain. Notably, the C domains of pseudopilin signal peptides
are located between the N and H domains (32, 33, 106, 148).
Accordingly, processing by pseudopilin-specific SPases, such as
ComC, takes place at the cytoplasmic side of the membrane
and leaves the H domain attached to the translocated protein.
While many proteins that end up in the extracellular milieu
or the cell walls of gram-positive bacteria have signal peptides,
proteins without known export signals can also be found at
these locations. The relative number of proteins without
known signal peptides seems to vary for each organism. While
these numbers are relatively low for B. subtilis and S. aureus,
they are high for group A streptococcus and M. tuberculosis
(174). As indicated above, some of the proteins without known
export signals appear to be liberated from the cell by lysis,
while others are actively exported, for example, via the ESAT-6
pathway. Although the precise export signal in proteins se-
creted via the ESAT-6 pathway has not yet been defined, a
WXG motif is shared by these proteins and may serve a func-
tion in protein targeting (140). Furthermore, the signal for
specific release of lysins via holins is presently not known.
Signal Peptide Predictions
Several prediction programs that are accessible through the
World Wide Web are useful tools for predicting whether a
given protein contains some type of sorting signal or SPase
cleavage site. The programs that we used in this and other
studies were SignalP-NN and SignalP-HMM, version 2.0 (136),
LipoP, version 1.0 (94), PrediSi (76), and Phobius (95). These
VOL. 70, 2006 SECRETOMICS OF STAPHYLOCOCCAL PATHOGENESIS 767
 o
n









programs were designed to identify Sec-type signal peptides,
N-terminal membrane anchors (Phobius), or lipoprotein signal
peptides in gram-negative bacteria (LipoP). The TMHMM
program, version 2.0 (41), was used to exclude proteins with
(predicted) multiple membrane-spanning domains. Predictions
for proteins containing a signal peptide were performed with
the SignalP program, using the neural network and hidden
Markov model algorithms. Version 2.0 of the SignalP program
was preferred above version 3.0 (12) for our signal peptide
predictions for S. aureus and S. epidermidis because the best
overall prediction accuracy was obtained with version 2.0 in a
recent proteomics-based verification of predicted export and
retention signals in B. subtilis (179). Specifically, the hidden
Markov model in SignalP 2.0 assigns a probability score to each
amino acid of a potential signal peptide and indicates whether
it is likely to belong to the N, H, or C domain. Proteins with no
detectable N, H, or C domain were excluded from the set.
Searching for transmembrane domains was performed with the
TMHMM program, and proteins with more than one (pre-
dicted) transmembrane domain were excluded from the set
because they most likely are integral membrane proteins. All
proteins with a predicted C-terminal transmembrane segment
in addition to a signal peptide were screened for the presence
of a conserved motif for covalent cell wall binding. It should be
noted that this approach does not automatically result in the
exclusion of potential membrane proteins with one N-terminal
transmembrane domain. The LipoP program was used to pre-
dict lipoproteins. The combined results of all these programs
resulted in a list of proteins which have (i) signal peptides with
distinctive N, H, and C domains, (ii) no additional transmem-
FIG. 5. General properties and classification of S. aureus signal peptides. Signal peptide properties are based on SPase cleavage sites and the
export pathways by which the preproteins are exported. Predicted signal peptides (144) were divided into the following five distinct classes:
secretory (Sec-type) signal peptides, twin-arginine (RR/KR) signal peptides, lipoprotein signal peptides, pseudopilin-like signal peptides, and
bacteriocin leader peptides. Most of these signal peptides have a tripartite structure, with a positively charged N domain (N) containing lysine
and/or arginine residues (indicated by plus signs), a hydrophobic H domain (H, indicated by a black box), and a C domain (C) that specifies the
cleavage site for a specific SPase. Where appropriate, the most frequently occurring amino acid residues at particular positions in the signal peptide
or mature protein are indicated. Also, the numbers of signal peptides identified for each class and the respective SPase are indicated.
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brane domains, and (iii) predicted extracytoplasmic localiza-
tions. These proteins were scanned for the presence of pro-
teomics-based consensus motifs for type I, type II, or
pseudopilin-specific SPase recognition and cleavage sites, twin-
arginine motifs, and known leader peptides of bacteriocins by
BLAST searches and by use of the PATTINPROT program
(http://npsa-pbil.ibcp.fr), as previously described (179). To de-
fine the core exoproteome and variant exoproteome of the S.
aureus strains, the sets of proteins with predicted signal pep-
tides were used in multiple BLAST searches with the freeware
BLASTall from the NCBI. The output was then filtered using
Genome2D (10).
Secretory (Sec-type) signal peptides. Proteomics-based data
sets of membrane, cell wall, and extracellular proteins were
extremely valuable for a recent verification of signal peptide
predictions for B. subtilis (179). Such data sets are now becom-
ing available for S. aureus, as exemplified by studies on the
membrane and cell wall proteomes of S. aureus Phillips (127)
and the extracellular proteomes of S. aureus strains derived
from the recently sequenced NCTC8325 and COL strains (208,
209) (Fig. 2). Additionally, the extracellular proteomes of sev-
eral clinical S. aureus isolates have been analyzed (Fig. 2). The
membrane, cell wall, and extracellular proteins of S. aureus
that have been identified by proteomics, involving 2D-PAGE
and subsequent mass spectrometry, are listed in Tables 4 and 5.
These tables also show the 3-to-1 amino acid sequences of
the respective signal peptidase cleavage sites, if present.
Based on the proteomics data for membrane and extracel-
lular proteins of B. subtilis, the optimized 3-to-1 pattern
(AVSTI)-(SEKYHQFLDGPW)-A-(AQVEKDFHLNS) for
signal peptide recognition and cleavage by type I SPases of this
organism was identified (179). SPase cleavage occurs C-termi-
nal of the invariant Ala residue at the 1 position. The resi-
dues in parentheses in the pattern are listed in the order of
frequency, with the most frequently identified residue at each
position being placed in the first position. By comparing the
predicted SPase recognition and cleavage sites for signal pep-
tides of proteomically identified extracellular proteins of S.
aureus (Table 4), we defined the 3-to-1 pattern (AVS)-
(KHNDQSYEGLR)-A-(AESDIKL) for productive recogni-
tion and cleavage by the type I SPase SpsB. Compared to the
equivalent pattern in B. subtilis, it is interesting that the fre-
quencies of certain residues at the 3, 2, and 1 positions
differ, as reflected by the order of frequency with which they
are listed in the pattern. Moreover, Asn can be present at the
2 position, while Ile is accepted at the 1 position. These
residues are found at the 2 and 1 positions of certain serine
proteases, hemolysins, immunoglobulin G (IgG) binding pro-
tein A, and aureolysin (Table 4). It should also be noted that
compared to the optimized SPase recognition pattern in B.
subtilis, several residues are not found at the 3, 2, and 1
positions of potential SpsB recognition and cleavage sites in
identified extracellular proteins of S. aureus. Since such resi-
dues may be present in SPase recognition and cleavage sites of
proteins that have escaped identification through proteomics,
we included them in the 3-to-1 search pattern (shown in
lowercase) for the identification of potential secretory proteins
of staphylococci, as follows: (AVSit)-(KHNDQSYEGLRfpw)-
A-(AESDIKLfhnqv). This optimized S. aureus search pattern
was used as an indicator of the quality of signal peptide pre-
dictions based on the SignalP-NN, SignalP-HMM, LipoP,
PrediSi, Phobius, and TMHMM programs. Proteins with po-
tential signal peptides containing this pattern were assigned to
have a high probability of extracytoplasmic localization and a
low probability of membrane retention (Tables 6 and 7). Pro-
teins with potential signal peptides that do not contain this
pattern were assigned to have a high probability of being re-
tained in the membrane (data not shown). In this case, the
uncleaved signal peptide could serve as an N-terminal mem-
brane anchor. Following this approach, sets of 186 to 211
proteins (depending on the S. aureus strain) were identified
that contain a potential signal peptide or N-terminal trans-
membrane segment. Scanning for the presence of the SpsB rec-
ognition and cleavage motif [(AVSit)-(KHNDQSYEGLRfpw)-
A-(AESDIKLfhnqv)] revealed that, depending on the S.
aureus strain investigated, 78 to 93 proteins carry this motif.
These proteins are most likely processed by SPase, liberated
from the membrane, and secreted into the extracellular milieu,
unless they contain a cell wall retention signal (see below).
Most of the other proteins with signal peptides that do not
conform to the SpsB recognition and cleavage motif lack the
invariant Ala at the 1 position. Also, some of these prepro-
teins contain different residues at the 3, 2, or 1 position.
For example, Asp, Glu, Phe, and Lys are highly unlikely resi-
dues at the 3 position (187). On the other hand, some pre-
proteins have a Gly (e.g., exotoxins 4 and 5 from S. aureus
COL) or a Leu at the 3 position (Tables 6 and 7). Since Gly
and Leu residues at the 3 position of signal peptides are
accepted by the E. coli SPase, it seems likely that they are also
accepted at this position by SpsB. However, we did not include
these residues in the current SpsB recognition and cleavage
motif, since we could neither identify these proteins among the
secreted proteins of S. aureus COL (Fig. 2) nor find published
evidence that these proteins are indeed secreted. Among the
proteins with predicted cleavable Sec-type signal peptides,
there are many known extracellular staphylococcal virulence
factors, such as exotoxins, enterotoxins (SEM, SEN, and SEO),
hemolysins, TSST-1, leukotoxins (LukD and LukE), a secre-
tory antigen SsaA homologue, and immunodominant antigen
A (IsaA). Remarkably, the lists of identified extracellular pro-
teins of S. aureus COL and RN6390 (208) (Tables 4 and 5)
reveal that about 48% of these proteins lack known signal
peptides. This percentage is substantially higher than the initial
estimate of 10%, which was based on a limited proteomics-
derived data set (174). It is also interesting that the list of
identified extracellular proteins without a signal peptide in-
cludes enolase, which may be actively exported by an unknown
mechanism (19), but lacks EsxA and EsxB, which are exported
by the ESAT-6 system (26).
Twin-arginine (RR) signal peptides. The consensus RR mo-
tif that directs proteins into the Tat pathway has previously
been defined as (KR)-R-X-#-#, where # is a hydrophobic
residue (39, 89). Dilks et al. (47) used a genomic approach to
identify possible Tat substrates for 84 diverse prokaryotes,
using the TATFIND 1.2 program. Their study included S.
aureus Mu50, MW2, and N315. Two potential Tat substrates of
unknown function were predicted for S. aureus Mu50 and
MW2, and one of these was also predicted for S. aureus N315
(47). However, both proteins are conserved in all sequenced S.
aureus strains, including the N315 strain. One of the two pre-
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TABLE 4. Identified proteins in extracellular proteomes of various S. aureus strains with known signal peptidesa
Identification
no. Protein Function
Amino acid at position:
Localization Motif i
3 2 1 1
15925728 SA0022 Hypothetical protein S N A A Extracellular LPKTG
15925799 Plc 1-Phosphatidylinositol phosphodiesterase
precursor
A H A S Extracellular
15925800 SA0092 Hypothetical protein T A G C Extracellular Lipo
15925815b Spa Immunoglobulin G binding protein A
precursor
A N A A Membrane/cell wall/
extracellular
LPETG
15925838c SasD Hypothetical protein A H A D Extracellular LPAAG
15925933 Coa Staphylocoagulase precursor A D A I Extracellular
15925978 LytM Peptidoglycan hydrolase A D A A Extracellular
15925983d SA0270 Hypothetical protein A Q A Y Extracellular
15926008 SA0295 Hypothetical protein A F A K Extracellular
15926022 Geh Glycerol ester hydrolase A Q A S Extracellular
15926073 SA0359 Hypothetical protein L T A C Extracellular Lipo
15926099 Set6 Exotoxin 6 V Q A K Extracellular
15926111 Set15 Exotoxin 15 V K A S Extracellular
15926112 SA0394 Hypothetical protein A E A S Extracellular
15926142 SA0423 Hypothetical protein A N A A Extracellular LysM
15926239e SdrC Ser-Asp-rich, fibrinogen-binding bone
sialoprotein-binding protein
A K A A Membrane/cell wall LPETG
15926241 SdrE Ser-Asp-rich, fibrinogen-binding bone
sialoprotein-binding protein
A K A A Extracellular LPETG
15926291 SA0570 Hypothetical protein A E A A Extracellular
15926342 SA0620 Hypothetical protein A Q A S Extracellular
15926373 SA0651 Hypothetical protein A L A K Extracellular
15926417 SA0695 Hypothetical protein I S A C Extracellular Lipo
15926548 GlpQ Glycerophosphoryl diester phosphodiesterase A G A E Extracellular
15926570 SA0841 Hypothetical protein V S A A Extracellular
15926634 SspB Cysteine protease precursor A K A D Extracellular
15926635 SspA Serine protease, V8 protease, glutamyl
endopeptidase
A N A L Extracellular
15926639 Atl Autolysin, N-acetylmuramyl-L-alanine amidase
and endo--N-acetylglucosaminidase
V Q A A Extracellular GW
15926739 SA1001 Hypothetical protein A K A F Extracellular
15926746 SA1007 -Hemolysin precursor A N A A Extracellular
15926969c SA1221 Thioredoxin reductase L G A C Extracellular Lipo
15927068 SA1318 Hypothetical protein L S G C Extracellular Lipo
15927383 SplF Serine protease SplF A K A E Extracellular 2 TMD
15927384e SplD Serine protease SplD A K A E Membrane/cell wall 2 TMD
15927385 SplC Serine protease SplC A N A E Extracellular
15927386 SplB Serine protease SplB A K A E Extracellular
15927387b SplA Serine protease SplA A K A E Membrane/cell wall
15927389 SA1633 Probable -lactamase A K A E Extracellular
15927393 LukD Leukotoxin, LukD V D A A Extracellular
15927394 f LukE Leukotoxin, LukE S R A N Extracellular
15927483 SA1725 Staphopain, cysteine proteinase A N A E Extracellular
15927517 SA1755 Hypothetical protein A K A F Extracellular
15927520b Sak Staphylokinase precursor V S A S Membrane/cell wall
15927580 SA1812 Hypothetical protein S Y A K Extracellular
15927581 SA1813 Hypothetical protein A N S A Extracellular
15927670 SA1898 Hypothetical protein A H A S Extracellular
15927785 SA2006 Hypothetical protein A S A D Extracellular
15927879 SsaA Hypothetical protein A H A S Extracellular
15927884 SA2097 Hypothetical protein A D A A Extracellular
15927988e SA2198 Hypothetical protein L T A C Membrane/cell wall Lipo
15927996 Sbi IgG-binding protein SBI A K A S Extracellular
15927998 HlgC 	-Hemolysin component C A K A A Extracellular
15927999 HlgB 	-Hemolysin component B A N A E Extracellular
15928148 IsaA Immunodominant antigen A A H A A Extracellular
15928216 ClfB Clumping factor B A Q A S Extracellular LPETG
15928223b Aur Zinc metalloproteinase aureolysin A L A I Membrane/cell wall
15928230 SA2437 Hypothetical protein A Y A D Extracellular
15928254e IcaB Intercellular adhesion protein B A N A D Membrane/cell wall
15928257 Lip Triacylglycerol lipase precursor A Q A A Extracellular
57652419 g Pls Methicillin-resistant surface protein A E A A Extracellular LPDTG
57651319 g SACOL0478 Exotoxin 3, putative V K A S Extracellular
Continued on following page
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dicted Tat substrates has no known function, whereas the other
was annotated as a hypothetical protein similar to a ferri-
chrome ABC transporter (permease). These proteins, how-
ever, are not in our list of proteins that have a predicted RR
signal peptide. Although they have signal peptides according
to the SignalP program, these proteins are localized in the
cytoplasm or membrane according to the LipoP, PrediSi, and
Phobius programs. It is therefore unlikely that these proteins
are destined for secretion. Specifically, the hypothetical per-
mease has eight predicted transmembrane helices.
Our own pattern searches for proteins with a possible RR
motif resulted in 24 to 32 positive hits, depending on the S.
aureus strain investigated. However, most of these proteins
have no detectable N, H, or C domain and were therefore
discarded from our data set. Also, some other proteins with a
possible RR motif are predicted to contain a lipoprotein signal
peptide. These predicted lipoproteins were also discarded
from the list of potential S. aureus Tat substrates, firstly be-
cause none of the identified lipoproteins of B. subtilis that have
an RR motif were shown to be secreted via the Tat pathway
(87, 89) and secondly because there is no published evidence
for any other bacterium that lipoproteins can be exported Tat
dependently. Thus, it appears that only four or five proteins,
depending on the S. aureus strain investigated, are potentially
exported by the Tat pathway and cleaved by SpsB. However, it
is noteworthy that none of the B. subtilis proteins with a KR
motif were secreted Tat dependently, even though KR motifs
are capable of directing proteins into the Tat pathways of
chloroplasts and gram-negative bacteria, such as E. coli and
Salmonella enterica (77, 82, 123, 167). If KR motifs are also
rejected by the S. aureus Tat pathway, there would not be a
single protein in any sequenced S. aureus strain that is secreted
Tat dependently. This would be highly remarkable in view of
the presence of tatA and tatC genes in all of these strains.
Notably, the only known strictly Tat-dependent extracellular
proteins of B. subtilis are the phosphodiesterase PhoD (175)
and a protein of unknown function, YwbN (88). While a ho-
mologue of PhoD is not present in any of the six sequenced S.
aureus strains, homologues of YwbN are present in all of these
strains. Close inspection of the YwbN homologues of S. aureus
COL, MRSA252, and MSSA476 revealed the presence of an
N-terminal RR motif, but a potential signal peptide was not
identified as such by the SignalP program. In contrast, the
YwbN homologues of S. aureus Mu50, MW2, and N315 appear
to lack this RR motif. According to comparisons of the de-
duced amino acid sequences, these three YwbN homologues
should be missing the first 40 residues of B. subtilis YwbN. This
is most likely not the case, since the sequences upstream of the
annotated S. aureus Mu50, MW2, and N315 ywbN genes en-
code a peptide with an RR motif in the same open reading
frame as the ywbN structural gene (Table 6). Thus, the RR
motifs of the S. aureus Mu30, MW2, and N315 YwbN proteins
have so far escaped identification due to a systematic differ-
ence in sequence annotation. It remains to be investigated
whether these sequences with RR motifs serve as signal pep-
tides in the Tat-dependent export of S. aureus YwbN homo-
logues.
Pseudopilin signal peptides. The signal peptides of pseudo-
pilins differ from the Sec-type signal peptides in the location of
SPase cleavage sites. In pseudopilin signal peptides, the cleav-
age site is located between the N and H domains (105). The
consensus recognition and cleavage motif for pseudopilin
SPases, such as ComC, is K-G-F-X-X-X-E. Cleavage by pseudo-
pilin SPases occurs within this motif, between the Gly and Phe
residues. Upon cleavage, the Phe residue is methylated. For all
sequenced S. aureus strains, three proteins were found to have
the canonical pseudopilin SPase recognition and cleavage mo-
tif. These proteins are homologues of the cold shock proteins
CspB, CspC, and CspD of B. subtilis. However, even though
these proteins do contain the pseudopilin SPase recognition
and cleavage pattern, they lack the H domain. Since the active
sites of pseudopilin SPases are located in the cytoplasm, cleav-
age of the CspBCD homologues of S. aureus would be possible,




Amino acid at position:
Localization Motif i
3 2 1 1
57651320g SACOL0479 Surface protein, putative A E A S Extracellular
57650159g Sek Staphylococcal enterotoxin A S A Q Extracellular
57650160g Sei Staphylococcal enterotoxin type I A Y A D Extracellular
57651597g Seb Staphylococcal enterotoxin B V L A E Extracellular
57651598g SACOL0908 Hypothetical protein A K A S Extracellular
57650600g SACOL1865 Serine protease SplE, putative A K A E Extracellular
57650605g SACOL1870 Hypothetical protein A K A E Extracellular
57650692g Hlb -Hemolysin/phospholipase C A K A E Extracellular
57651004g SACOL2505 Cell wall surface anchor family protein A E A A Extracellular LPKTG
24636603h Etd Exfoliative toxin D S H A E Extracellular
24636604h Probable glutamyl-endopeptidase V S A S Extracellular
a The annotation of proteins is based on that of S. aureus N315, except for those proteins that are not encoded by the N315 genome.
b Also found in membrane/cell wall fraction by Nandakumar et al. (127).
c Found only in extracellular proteome described by Ziebandt et al. (208). Note that SA1221 is probably not a thioredoxin reductase, but a phosphate binding protein.
d Tyr is not present at the 1 position of the optimized S. aureus SpsB search pattern.
e Found only in membrane/cell wall fraction by Nandakumar et al. (127).
f Arg is not present at the 2 position of the optimized S. aureus SpsB search pattern.
g Encoded by S. aureus COL and absent from N315.
h Note that the corresponding gene is not present in the sequenced S. aureus genomes.
i TMD, transmembrane domain.
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it should be noted that one of the CspBCD homologues of S.
aureus, known as CspA, was found in the extracellular pro-
teome of a clinical isolate (Fig. 2 and Table 5). To verify the
absence or presence of pseudopilins in S. aureus, BLAST
searches with the known ComGC, ComGD, ComGE, and
ComGG proteins of B. subtilis were performed. This revealed
the presence of only one potential pseudopilin, which is a
homologue of B. subtilis ComGC. Although the consensus
pseudopilin SPase recognition and cleavage site is absent from
S. aureus ComGC, a putative cleavage pattern (Q-A-F-T-L-
I-E) is present at the position in the ComGC signal peptide
where a pseudopilin SPase recognition and cleavage site would
be expected. Further analyses revealed that similar observa-
tions can be made for ComGC homologues in other gram-
positive bacteria, such as Bacillus cereus, B. anthracis, L. mono-
cytogenes, S. haemolyticus, and Oceanobacillus iheyensis. By
comparing the ComGC homologues of these organisms, an
expanded search pattern for gram-positive bacterial pseudo-
pilin SPase recognition and cleavage sites was defined as fol-
lows: (KEQRS)-(GA)-F-X-X-X-E. Interestingly, using this ex-
panded search pattern, two additional potential pseudopilins
of S. aureus were identified. These potential pseudopilins show
similarity to the ComGD proteins of B. cereus and B. anthracis
and the ComGF proteins of Bacillus halodurans and L. lactis. It
remains to be shown whether the three identified potential
pseudopilins of S. aureus are indeed able to assemble into
pilin-like structures after being processed by the ComC homo-
logue. If so, it will be even more interesting to identify their
biological function, for example, in adhesion to surfaces, mo-
tility, or export of proteins. Such functions could play a role in
virulence and have been attributed to type IV pili and pseudo-
pilins of gram-negative bacteria (106).





15925748a XylR Hypothetical protein 15926930 CitB Aconitate hydratase
15926081a AhpF Alkyl hydroperoxide reductase subunit F 15926982c CspA Major cold shock protein CspA
15926082b AhpC Alkyl hydroperoxide reductase subunit C 15926993 OdhA 2-Oxoglutarate dehydrogenase E1
15926091b GuaB Inositol-monophosphate dehydrogenase 15927003 SA1255 PTS system, glucose-specific enzyme II,
15926092 GuaA GMP synthase A component
15926202 ClpC HSP100/Clp ATPase 15927005 SA1257 Peptide methionine sulfoxide reductase
15926205 GltX Glutamyl-tRNA synthetase 15927057 SA1308 30S ribosomal protein S1
15926225b Fus Translational elongation factor G 15927062 EbpS Elastin binding protein
15926226b TufA Translational elongation factor TU 15927092 Gnd Phosphogluconate dehydrogenase
15926266 Pta Phosphotransacetylase 15927109 SA1359 Translation elongation factor EF-P
15926385 SA0663 Hypothetical protein 15927132 Pbp3 Penicillin binding protein 3
15926396b YfnI Hypothetical protein with five transmembrane 15927133 SodA Superoxide dismutase SodA
segments and a potential SPase I cleavage site 15927160b DnaK DnaK protein
15926429 SA0707 Hypothetical protein 15927161 GrpE GrpE protein
15926441 TrxB Thioredoxin reductase 15927190 GreA Transcription elongation factor
15926445 ClpP Peptidase 15927229 SA1475 Hypothetical protein
15926449b Gap Glyceraldehyde-3-phosphate dehydrogenase 15927254 Tig Trigger factor (prolyl isomerase)
15926450 Pgk Phosphoglycerate kinase 15927273 CitZ Citrate synthase II
15926451 Tpi Triosephosphate isomerase 15927286 Ald Alanine dehydrogenase
15926452 Pgm 2,3-Diphosphoglycerate-independent 15927287 SA1532 Hypothetical protein
phosphoglycerate mutase 15927309b Fhs Formyltetrahydrofolate synthetase
15926453b Eno Enolase 15927328 SA1572 Hypothetical protein
15926468 SA0746 Staphylococcal nuclease with two transmembrane 15927409 TRAP Signal transduction protein TRAP
segments and a potential SPase I cleavage site 15927495 SA1737 Hypothetical protein
15926503 SA0775 Hypothetical protein 15927539 SA1774 Hypothetical protein
15926543 SA0806 Hypothetical protein 15927604b GroEL GroEL protein
15926551 Pgi Glucose-6-phosphate isomerase A 15927605 GroES GroES protein
15926589 SA0859 Hypothetical protein 15927640 RsbW Anti-
B factor
15926642 SA0908 Hypothetical protein predicted to have an uncleaved 15927687 GlyA Serine hydroxymethyl transferase
signal peptide 15927699 FbaA Fructose-bisphosphate aldolase
15926669 PtsH Phosphocarrier protein Hpr, phosphohistidine- 15927712 DeoD Purine nucleoside phosphorylase
containing protein 15927753 SAS074 Hypothetical protein
15926670 PtsI Phosphoenolpyruvate-protein phosphatase 15927762 Asp23 Alkaline shock protein 23, Asp23
15926679 PdhB Pyruvate dehydrogenase E1 component beta subunit 15927994 SA2204 Hypothetical protein
15926680 PdhC Dihydrolipoamide S-acetyltransferase component of 15927798 RplM 50S ribosomal protein L13
pyruvate dehydrogenase complex E2 15928070 SA2279 Hypothetical protein
15926681b PdhD Dihydrolipoamide dehydrogenase component of 15928081 FnbB Fibronectin binding protein B
pyruvate dehydrogenase E3 15928082 FnbA Fibronectin binding protein A
15926710 SA0974 Hypothetical protein 15928133 RocA 1-Pyrroline-5-carboxylate dehydrogenase
15926723 PheT tRNAPhe synthetase  chain 15928185 PanB 3-Methyl-2-oxobutanoate hydroxymethyltransferase
15926735 SA0998 Hypothetical protein 15928192 SA2399 Fructose-bisphosphate aldolase
15926776 IleS tRNAIle synthetase 15928284 SA2490 Hypothetical protein
15926829 SucD Succinyl-coenzyme A synthetase,  subunit 57651372 MetS Methionyl-tRNA synthetase
15926840 Tsf Elongation factor TS 57651442 SACOL0613 Hypothetical protein
15926857 PnpA Polyribonucleotide nucleotidyltransferase 57651702 PdhA Pyruvate dehydrogenase complex E1 component,
15926892 GlnA Glutamine-ammonia ligase  subunit
15926915 KatA Catalase 24636605d Edin-B Epidermal cell differentiation inhibitor B
15926923b Tkt Transketolase
a Found only in the extracellular proteome described by Ziebandt et al. (208).
b Also found in the extracellular proteome described by Ziebandt et al. (208).
c Contains a pseudopilin SPase recognition and cleavage site.
d Note that the corresponding gene is not present in the sequenced S. aureus genomes.
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TABLE 6. The core exoproteome of S. aureus, defined as proteins with predicted Sec-type signal peptides present in all sequenced strains l
Identification
no. Protein
Amino acid at position:
Function
3 2 1 1
15925728 a, b SA0022 S N A A Hypothetical protein
15925815 a Spa A N A A Immunoglobulin G binding protein A precursor
15925838 c SA0129 A H A D Hypothetical protein
15925848 d SA0139 S L A I Hypothetical protein
15925933 Coa A D A I Staphylocoagulase precursor
15925978 LytM A D A A Peptidoglycan hydrolase
15926008 SA0295 A F A K Hypothetical protein
15926022 d Geh A Q A S Glycerol ester hydrolase
15926106 e Set13 V H A K Exotoxin 13
15926112 SA0394 A E A S Hypothetical protein
15926142 d, f SA0423 A N A A Hypothetical protein
15926239 a, d SdrC A K A A Ser-Asp-rich fibrinogen-binding protein
15926291 d SA0570 A E A A Hypothetical protein
15926319 d, g, h Pbp4 A Q A T Penicillin binding protein 4
15926342 f, d SA0620 A Q A S Secretory antigen SsaA homologue
15926373 d SA0651 A L A K Hypothetical protein
15926432 f, d SA0710 A H A Q Hypothetical protein
15926464 a ClfA A D A S Fibrinogen-binding protein A
15926466 Ssp A K A A Extracellular matrix and plasma binding protein
15926467 SA0745 A N A L Hypothetical protein
15926548 h GlpQ A G A E Glycerophosphoryl diester phosphodiesterase
15926570 SA0841 V S A A Hypothetical protein
15926634 SspB A K A D Cysteine protease precursor
15926635 d SspA A N A L Serine protease
15926639 f, d Atl V Q A A Autolysin
15926713 a IsdB A Q A A Hypothetical protein
15926714 a IsdA V N A A Cell surface protein
15926715 i IsdC A N A A Hypothetical protein
15926738 SA1000 S H A Q Hypothetical protein
15926741 Efb A D A S Hypothetical protein
15926742 SA1004 A D A S Hypothetical protein
15926750 SA1010 S E A K Hypothetical protein
15926830 f LytN A Y A D LytN protein
15927055 d GpsA V L A E Glycerol-3-phosphate dehydrogenase
15927385 SplC A N A E Serine protease SplC
15927456 d SA1698 S L A D Hypothetical protein
15927483 d SspB2 A N A E Staphopain, cysteine proteinase
15927580 SA1812 S Y A K Hypothetical protein
15927607 d SA1839† V E A K Hypothetical protein
15927670 d SA1898 A H A S Hypothetical protein
15927785 SA2006 A S A D Hypothetical protein
15927879 d SsaA A H A S Hypothetical protein
15927884 d SA2097 A D A A Hypothetical protein
15927996 Sbi A K A S IgG-binding protein Sbi
15927997 HlgA S K A E 	-Hemolysin chain II precursor
15927998 HlgC A K A A 	-Hemolysin component C
15927999 HlgB A N A E 	-Hemolysin component B
15928114 SA2323 A Y A H Hypothetical protein
15928123 d SA2332 S H A A Hypothetical protein
15928145 d SA2353 A Q A A Hypothetical protein
15928148 d IsaA A H A A Immunodominant antigen A
15928216 a ClfB A Q A S Clumping factor B
15928223 d, j Aur A L A I Zinc metalloproteinase aureolysin
15928224 d, k IsaB A Q A A Immunodominant antigen B
15928230 d SA2437 A Y A D Hypothetical protein
15928232 c, d SasF A Q A A Conserved hypothetical protein
15928254 IcaB A N A D Intercellular adhesion protein B
15928257 d Lip A Q A A Triacylglycerol lipase precursor
a Contains an LPXTG motif.
b Protein homologue of B. subtilis is found in extracellular proteome (174).
c Contains an LPXAG motif.
d Also present in S. epidermidis.
e Only the S. aureus COL protein has a Thr at the 1 position, which is not included in the recognition and cleavage pattern. All other S. aureus strains conform
to the proposed pattern.
f Contains a LysM or GW domain motif.
g Only the S. aureus N315 protein has a Thr at the 1 position, which is not included in the recognition and cleavage pattern. All other S. aureus strains conform
to the proposed pattern.
h Protein homologues of B. subtilis are classified as Sec-attached membrane proteins (179).
i Contains an NPQTN motif.
j Protein homologue of B. subtilis classified as a secretory protein (179).
k Only for the S. aureus MRSA252 protein; protein homologues in other strains are predicted to have two transmembrane domains and were excluded from the list.
l Signal peptide predictions were performed with SignalP-NN and SignalP-HMM, version 2.0 (136; http://www.cbs.dtu.dk/services/SignalP-2.0/), PrediSi (76; http://www
.predisi.de/), Phobius (95; http://phobius.cgb.ki.se/), and LipoP, version 1.0 (94; http://www.cbs.dtu.dk/services/LipoP/). These programs are designed to identify Sec-type
signal peptides, amino-terminal membrane anchors (Phobius), or lipoprotein signal peptides in gram-negative bacteria (LipoP). The TMHMM program, version 2.0
(41; http://www.cbs.dtu.dk/services/TMHMM/), was used to identify transmembrane segments in proteins.
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TABLE 7. Variant exoproteome of S. aureus, defined as proteins with predicted Sec-type signal peptides present in
at least one sequenced strain
Identification
no. Protein
Amino acid at position:
Function
3 2 1 1
15925799 Plc A H A S 1-Phosphatidylinositol phosphodiesterase precursor
15926099a Set6 V Q A K Exotoxin 6
15926100a Set7 V H A E Exotoxin 7
15926101a Set8 V K A E Exotoxin 8
15926103a Set10 V N A S Exotoxin 10
15926104a Set11 V H A K Exotoxin 11
15926105a Set12 V N A K Exotoxin 12
15926106a Set13 V H A K Exotoxin 13
15926111a Set15 V K A S Exotoxin 15
15926113 SA0395 A D A K Hypothetical protein
15926465 SA0743 A S A V Hypothetical protein
15926739 SA1001 A K A F Hypothetical protein
15926746 HlY A N A A -Hemolysin precursor
15927016b EbhB A H A A Hypothetical protein
15927308c Fhs A Q A A Hypothetical protein
15927386 SplB A K A E Serine protease SplB
15927387 SplA A K A E Serine protease SplA
15927389 SA1633 A K A E Probable -lactamase
15927393 LukD V D A A Leukotoxin, LukD
15927398 SEG V N A Q Extracellular enterotoxin type G precursor
15927399 SEN V N A E Enterotoxin SeN
15927402 SEI T Y A Q Extracellular enterotoxin type I precursor
15927404 SEO A Y A N Enterotoxin SeO
15927512 Map A S A A Truncated MapW protein
15927513 Hlb A K A E Truncated -hemolysin
15927516 SA1754 A Q A S Hypothetical protein
15927517 SA1755 A K A F Hypothetical protein
15927520 Sak V S A S Staphylokinase precursor
15927522 SA1760 A K A I Hypothetical protein
15927585 SEC3 V L A E Enterotoxin type C3
15927586 SA1818 A K A E Hypothetical protein
15927587 TSST-1 A K A S Toxic shock syndrome toxin 1
15927741c FmtB A S A A FmtB protein
15928076b,c SA2285 A E A A Hypothetical protein
15928174c SA2381 A N A E Hypothetical protein
15928182 SA2389 V L A D Hypothetical protein
16119203 SAP003 A Y A N Hypothetical protein
16119219 SAP019 A E A A Hypothetical protein
14141830 SAVP008 A N A E Hypothetical protein
21282111 Set16 V Q A K Hypothetical protein
21282116 Set21 V K A A Hypothetical protein
21282123 Set26 V K A I Hypothetical protein
21283107 LukF V D A A Panton-Valentine leukocidin chain F precursor
21283108 LukS S K A D Panton-Valentine leukocidin chain S precursor
21284341c Cna A L A A Collagen adhesin precursor
49482651 SAR0423 V H A E Exotoxin
49482652 SAR0424 A N A E Exotoxin
49482653 SAR0425 A N A E Exotoxin
49482925b SAR0721 T F A E Multicopper oxidase protein
49484047 SAR1886 A Y A F Putative exported protein
49484059b SAR1905 A K A E Serine protease
49484898 SAR2788 A E A S Putative exported protein
49484957 SEH A K A E Enterotoxin H
49485293 SAS0389 V K A A Exotoxin
57650600 SACOL1865 A K A E Serine protease SplE, putative
57650605 SACOL1870 A K A E Hypothetical protein
57650609 EpiP A S A S Epidermin leader peptide processing serine
protease EpiP
57651309 SACOL0468 V Q A K Exotoxin 3, putative
57651311 SACOL0470 V K A E Exotoxin, putative
57651319 SACOL0478 V K A S Exotoxin 3, putative
57652419c Pls A E A A Methicillin-resistant surface protein
a Although these proteins share homology with exotoxins from other S. aureus strains, they are highly variable (80).
b Also present in S. epidermidis.
c Contains an LPXTG motif.
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Bacteriocin leader peptides. Bacteriocins form a distinct
group of proteins with cleavable N-terminal signal peptides,
which are often called leader peptides. These leader peptides
only have N and C domains and completely lack the hydro-
phobic H domain. The bacteriocin leader peptides are invoked
in posttranslational modification and the prevention of prema-
ture antimicrobial activity, which would be deleterious to the
producing organism. Of the sequenced S. aureus bacteriocins,
C55 and C55 contain a leader peptide (130), whereas leader
peptides are absent from aureocin A53 (134) and aureocin A70
(134). Two potential lantibiotics with leader peptides were
identified by sequencing the genomes of S. aureus MW2 (7)
(GI numbers 49486642 and 49486641) and MSSA476. In both
strains, the corresponding genes are located on the genomic
island SA. Both S. aureus proteins show similarity to the
lantibiotic gallidermin precursor GdmA of Staphylococcus
gallinarum and to the lantibiotic epidermin precursor EpiA of
S. epidermidis. Notably, the S. aureus COL strain contains only
one of these two potential lantibiotics, which is most similar to
the potential MW2 lantibiotic under GI number 49486641.
Two additional putative bacteriocins that were identified by
genome sequencing seem to be homologous to L. lactis lacto-
coccin 972. The hypothetical protein SAP019 (N315 annota-
tion) is plasmid encoded in S. aureus N315 and MSSA476 and
chromosomally encoded in S. aureus MRSA252. The other
hypothetical bacteriocin, SAS029, is chromosomally encoded
in all sequenced S. aureus strains. No published data are pres-
ently available on the characteristics of these proteins, so it
remains to be seen whether they are genuine bacteriocins.
Potential ESAT-6 export signal. As described above, the
EsxA and EsxB proteins are secreted by S. aureus via the
ESAT-6 route (26). Both proteins lack a known signal peptide
but are specifically transported across the membrane nonethe-
less. This implies that these two proteins must contain an
export signal that is recognized by one or more ESAT-6 path-
way components. The nature of this signal is presently un-
known. The only common feature of proteins that are known
(or predicted) to be translocated across the membrane via the
ESAT-6 pathway is a WXG motif, which is located 100
amino acids from the N terminus of the protein (140). The
involvement of the WXG motif in ESAT-6 targeting remains
to be demonstrated.
Retention Signals
Lipoproteins. Lipoproteins appear to be exported via the
Sec pathway. During or shortly after translocation, the invari-
ant Cys in the lipobox is diacylglyceryl modified by Lgt. This
results in signal peptide cleavage by SPase II and retention of
the mature lipoprotein in the membrane. Based on the cleav-
age sites of lipoproteins that have been identified in various
gram-positive bacteria, Sutcliffe and Harrington (171) reported
the 4-to-2 lipobox pattern (LIVMFESTAG)-(LVIAMGT)-
(IVMSTAFG)-(AG)-C-(SGANERQTL). Furthermore, they
reported that neither the charged residues Asp, Glu, Arg, and
Lys nor Gln is present in the region between 6 and 20 residues
N-terminal of the lipobox. A search of the translated proteins
encoded by the six S. aureus genomes with the pattern shown
above, using the PATTINPROT program, revealed about 50
proteins with this motif (Tables 8 and 9). A comparison of the
PATTINPROT results to the results obtained with the LipoP
program showed that 10 to 16 more potential lipoproteins may
be present in S. aureus. Most of these extra predicted lipopro-
teins contain an amino acid at the 1 position (mostly Ser) or
the 2 position (mostly Asp) that differs from the lipobox
pattern reported by Sutcliffe and Harrington (171). Recently,
Tjalsma and van Dijl (179) proposed the lipobox search pat-
tern (LITAGMV)-(ASGTIMVF)-(AG)-C-(SGENTAQR) for
potential lipoproteins of B. subtilis on the basis of published
proteomics data. The only difference compared to the pattern
by Sutcliffe and Harrington (171) is that Leu is absent from the
2 position, which is due to the fact that no potential B. subtilis
lipoprotein with Leu at this position was identified by proteo-
mics. Consistently, none of the predicted S. aureus lipoproteins
has a Leu at the 2 position (Tables 8 and 9). It is also
noteworthy that some lipoproteins contain a (KR)-R-X-#-#
motif in their signal peptides, although it has not been shown
yet that lipoproteins can be transported via the Tat pathway.
Finally, the hypothetical protein Lpl2 of S. aureus N315 and
Mu50 was excluded from our lipoprotein predictions because
Asp does not seem to occur at the 2 position of lipoproteins
from gram-positive bacteria (94, 179). Nevertheless, the homo-
logues of Lpl2 of the other sequenced S. aureus strains are
classified as lipoproteins because they have residues at the 2
position that conform to the lipobox consensus.
Lipoprotein release determinant. Although lipoproteins
were generally believed to be retained at the membrane-cell
wall interface, the presence of lipoproteins in the growth me-
dium of B. subtilis was documented by Antelmann et al. (3).
This unexpected finding was correlated with the proteolytic
removal of the amino-terminal, lipid-modified Cys, which sug-
gests that the observed lipoprotein release into the growth
medium was caused by proteolytic “shaving” after processing
by LspA. In most of these lipoproteins, Tjalsma and van Dijl
(179) identified the 1-to-10 consensus sequence C-G-
(NSTF)-X-(SGN)-X-(SGKAE)-X-X-(SGA), which might rep-
resent the recognition site for an as yet unidentified shaving
protease. Most probably, a Gly at the 2 position is of major
importance for lipoprotein release into the growth medium,
while a Ser at this position seems to inhibit the process. In the
sequenced genomes of S. aureus, a gene for only one lipopro-
tein with the exact motif described above could be found. By
searching for patterns with 80% similarity to the consensus
sequence (i.e., one different residue), five to seven additional
lipoproteins could be found, depending on the S. aureus strain.
Thr was not found at the 3 position in any of these proteins.
Instead, a Lys was identified at this position in one or two
predicted lipoproteins with a potential release motif, depend-
ing on the S. aureus strain. In other predicted lipoproteins with
a potential release motif, no Gly or Ala residue was found at
the 7 position. However, one of these lipoproteins contains a
predicted release motif with a Gln at the 7 position. To date,
a total of four potential lipoproteins have been identified in the
extracellular milieu of S. aureus. The first one was identified by
Ziebandt et al. (208). This protein was annotated as a thiore-
doxin reductase (Table 4), but it shows no similarity to known
thioredoxin reductases. Instead, it is highly similar to phos-
phate-binding lipoproteins, such as PstS of B. subtilis. It should
be noted that this protein was not predicted to be a lipopro-
tein because the signal peptide contains a Gln residue in the
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N domain. According to the search profile of Sutcliffe and
Harrington (171), lipoproteins do not contain a Gln residue at
this position. On the other hand, PstS of B. subtilis is a lipopro-
tein, and it would seem quite likely that this is also true for its
S. aureus homologue. The other three potential lipoproteins
were identified in the growth media of clinical isolates (Table
4). Remarkably, none of the four lipoproteins with extracellu-
lar localization contain the complete lipoprotein release motif
that was identified in extracellular lipoproteins of B. subtilis.
However, they do contain a Gly residue at the 2 position,
TABLE 8. Core lipoproteome of S. aureus, defined as proteins with predicted lipoprotein signal peptides present in all sequenced strains
Identification
no. Protein
Amino acid at position:
Function
3 2 1 1 2
15925800 SA0092 T A G C G Hypothetical protein
15925819 SirA L A G C S Lipoprotein
15925847a SA0138 A A A C G Hypothetical protein, similar to alkylphosphonate ABC
transporter
15925912 Slp L S G C G RGD-containing lipoprotein
15925918 SA0207 V T A C G Hypothetical protein, similar to maltose/maltodextrin-binding
protein
15925928a,b SA0217 L S S C A Hypothetical protein, similar to periplasmic-iron-binding
protein BitC
15925940c SA0229 L S G C G Hypothetical protein, similar to nickel ABC transporter
nickel-binding protein
15926044 SA0331 I A A C G Conserved hypothetical protein
15926073 SA0359 L T A C G Conserved hypothetical protein
15926079a SA0363 L T G C A Hypothetical protein
15926141a,d SA0422 L A A C G Hypothetical protein, similar to lactococcal lipoprotein
15926287a SA0566 L S G C G Hypothetical protein, similar to iron-binding protein
15926308a SA0587 V A A C G Lipoprotein, streptococcal adhesin PsaA homologue
15926354a SA0632 L T G C G Conserved hypothetical protein
15926385a,e SA0663 L G A C G Hypothetical protein
15926413 a, f SA0691 L A A C G Lipoprotein, similar to ferrichrome ABC transporter
15926417a SA0695 I S A C G Hypothetical protein
15926461 SA0739 L G A C G Conserved hypothetical protein
15926499 a, g SA0771 L A A C G Conserved hypothetical protein
15926579a SA0849 L S G C A Hypothetical protein, similar to peptide binding protein OppA
15926625 SA0891 V A G C G Hypothetical protein, similar to ferrichrome ABC transporter
15926678a SA0943 L A G C T Conserved hypothetical protein
15926717h IsdE L T S C Q Hypothetical protein
15926796a SA1056 V A G C S Hypothetical protein
15926969h SA1221 L G A C G Thioredoxin reductase
15927111a,e SA1361 L A G C G Hypothetical protein
15927372h SA1616 L S S C G Hypothetical protein
15927375a SA1619 L T A C G Hypothetical protein
15927415a PrsA L G A C G Peptidyl-prolyl cis/trans isomerase homolog
15927477a SA1719 L A A C G Conserved hypothetical protein
15927757a,i SA1979 V A A C G Hypothetical protein, similar to ferrichrome ABC transporter
(binding protein)
15927864g SA2079 L A A C G Hypothetical protein, similar to ferrichrome ABC transporter
FhuD precursor
15927948a SA2158 L A A C G Hypothetical protein, similar to TpgX protein
15927961 a, h SA2171 L I V C I Hypothetical protein
15927984a DsbA L A A C G DsbA; hypothetical protein similar to Zn-binding lipoprotein
AdcA
15927987c SA2197 L T A C G Conserved hypothetical protein
15927988c SA2198 I S G C G Hypothetical protein
15927992 a, g SA2202 L A A C G Hypothetical protein, similar to ABC transporter, periplasmic
amino acid-binding protein
15928025a OpuCC L S G C S Glycine betaine/carnitine/choline ABC transporter OpuC
15928037a SA2247 L S A C G Conserved hypothetical protein
15928046a Opp-1A L T G C G Oligopeptide transporter putative substrate binding domain
15928066a,i SA2275 I G A C G Hypothetical protein
15928267h SA2473 L Y S C S Hypothetical protein
a Also present in S. epidermidis.
b Excluded for S. aureus Mu50 and N315 because of the motif proposed by Sutcliffe and Harrington (171).
c Excluded for S. epidermidis because of the motif proposed by Sutcliffe and Harrington (171).
d Contains the lipoprotein release motif (179) with one amino acid change, except for S. aureus COL and S. epidermidis.
e Contains the lipoprotein release motif (179) with one amino acid change for all staphylococcal strains.
f Contains the exact lipoprotein release motif (179), except in S. epidermidis.
g Contains the lipoprotein release motif (179) with one amino acid change, except in S. epidermidis.
h Excluded for all S. aureus strains because of the motif proposed by Sutcliffe and Harrington (171).
i Contains the lipoprotein release motif (179) with one amino acid change, only for S. epidermidis.
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which strengthens the idea that this amino acid residue is
probably important for lipoprotein release. It is interesting
that in lipoproteins of gram-negative bacteria, an Asp, Gly,
Phe, or Trp residue at the 2 position prevents transport of
the mature lipoprotein to the outer membrane (128, 181). In
gram-positive bacteria, no outer membrane is present, and it
is currently not known whether the residue at the 2 posi-
tion has a role in subcellular protein sorting. However, a Gly
at this position does seem to promote lipoprotein release
into the extracellular milieu, not only in B. subtilis but also
in S. aureus.
Cell wall binding domains. Proteins that have to be dis-
played on the bacterial surface must be retained by noncova-
lent or covalent binding to the peptidoglycan moiety of the cell
wall. In B. subtilis, several proteins involved in cell wall turn-
over contain repeated domains in the C-terminal part of the
protein which have affinity for cell wall components (62, 110,
150). Specifically, the B. subtilis proteins LytD, WapA, YocH,
YvcE, and YwtD have been reported to bind to the cell wall
(62, 110, 150). While WapA is not conserved in staphylococci,
various S. aureus proteins with regions that show amino acid
sequence similarity to LytD, YocH, YvcE, and YwtD of B.
TABLE 9. Variant lipoproteome of S. aureus, defined as proteins with predicted lipoprotein signal peptides present in
at least one sequenced strain
Identification
no. Protein
Amino acid at position:
Function
3 2 1 1 2
15925801a SA0093 F A G C G Hypothetical protein
15925803 SA0095 T A G C G Hypothetical protein
15925804 SA0096 T A G C G Hypothetical protein
15925877a SA0167 I T G C D Hypothetical protein, similar to membrane lipoprotein SrpL
15926004 SA0291 L A G C S Hypothetical protein
15926114b Lpl1 I A G C G Hypothetical protein
15926115a Lpl2 I I G C D Hypothetical protein
15926116 Lpl3 I A G C G Hypothetical protein
15926118 Lpl4 I I G C G Hypothetical protein
15926119 Lpl5 V A G C G Hypothetical protein
15926120a Lpl6 I I G C D Hypothetical protein
15926122a Lpl8 A T S C G Hypothetical protein
15926123 Lpl9 I G G C G Hypothetical protein
15926465a SA0743 G A L C V Hypothetical protein
15926580c SA0850 L S A C G Hypothetical protein, similar to oligopeptide ABC
transporter oligopeptide-binding protein
15927067 SA1317 L S G C S Hypothetical protein
15927068d SA1318 L S G C S Hypothetical protein
15927069 SA1319 L S G C S Hypothetical protein
15927373b SA1617 L S A C S Hypothetical protein
15927396c SA1640 L V A C G Conserved hypothetical protein
15927859d ModA L A G C S Probable molybdate-binding protein
19528064a SA2273 I G G C I Hypothetical protein
21281801 Mw0072 T A G C G Staphylococcus tandem lipoprotein
21282126 Lpl10 I A G C G Hypothetical protein
21282127a Lpl11 V T S C G Hypothetical protein
21282129a Lpl13 I I G C D Hypothetical protein
21283103 MW1374 L S G C S Conserved hypothetical protein
21283167 MW1438 L T A C G Hypothetical protein
21284135 MW2406 I G A C G Hypothetical protein
21284306 MW2577 V S G C S Hypothetical protein
49482670 SAR0445 I G G C G Putative lipoprotein
49483993d BlaZ L S A C N -Lactamase precursor
49484246d SAR2104 L S A C G Putative lipoprotein
49484287a SAR2149 L I V C G Hypothetical protein
49484977d,e SAS0074 I G G C G Putative lipoprotein
57650161 SACOL0888 L G A C G Pathogenicity island, putative lipoprotein
57650441 SACOL1528 L S G C S Hypothetical protein
57650444 SACOL1531 L S G C S Hypothetical protein
57650485 SACOL1574 L S A C G Hypothetical protein
57650696 SACOL2010 L T A C S Iron compound ABC transporter, iron compound-binding
protein
57651323a SACOL0482 I M G C D Staphylococcus tandem lipoprotein
57652445 SACOL0081 T A G C G Hypothetical protein
14141829a SAVP006 L V S C N Hypothetical protein
a Excluded for all S. aureus strains because of the motif proposed by Sutcliffe and Harrington (171).
b Excluded for S. aureus COL, MSSA476, Mu50, MW2, and N315 because of the motif proposed by Sutcliffe and Harrington (171).
c Contains the lipoprotein release motif (179) with one amino acid change.
d Also present in S. epidermidis.
e Contains the lipoprotein release motif for S. epidermidis (179), with one amino acid change.
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subtilis can be found by BLAST searches. Accordingly, these S.
aureus proteins may be cell wall bound, but this remains to be
shown.
One of the domains that have affinity for cell wall compo-
nents is the “lysin motif,” or LysM domain, which was first
described for bacterial lysins (146). The number of LysM do-
mains can differ for wall-bound proteins from different gram-
positive bacterial species (168). For example, XlyA of B. sub-
tilis contains only one LysM domain, whereas three domains
can be detected in AcmA of L. lactis and five or six domains
can be detected in muramidases from Enterococcus species
(92). Using the LysM domain of AcmA from L. lactis in
BLAST searches against the six sequenced and annotated S.
aureus genomes, four proteins with one or more LysM domains
were detected. These proteins include a hypothetical protein
similar to autolysins (SA0423), a secretory antigen SsaA ho-
mologue (SA0620), a conserved hypothetical protein (SA0710),
and the LytN protein.
A different domain that can facilitate protein binding to the
cell wall is the GW domain. In L. monocytogenes, the surface-
exposed InlB protein contains three C-terminal GW domains.
Each domain consists of 80 amino acids and starts with a Gly
and a Trp residue (22). This domain specifically binds to lipo-
teichoic acids in the cell wall (91), thereby facilitating the
interaction of L. monocytogenes with components of human
host cells. The only protein with GW domains found in the
sequenced S. aureus strains is the autolysin protein Atl (5, 6).
This bifunctional autolysin contains three GW repeats of 97
amino acids. The protein is exported as a prepro-Atl precursor
of 1,256 amino acids. Subsequent processing steps result in the
removal of the signal peptide and the propeptide and the
separation of the mature region into an amidase and a glu-
cosaminidase (139). A similar separation of the mature region
into an amidase and glucosaminidase has been reported for the
AtlE protein of S. epidermidis (74). The GW repeats are both
necessary and sufficient to direct reporter proteins to the equa-
torial surface rings of S. aureus cells, where cell division starts.
Other S. aureus wall proteins that contain repeated domains
with potential wall binding properties have been described.
These include the clumping factors A and B (ClfAB) (70, 135),
several serine-aspartate repeat proteins (SdrCDE) (93), the
homologue of S. gordonii GspB (SasA) (165) (see “Covalent
attachment to the cell wall” below), and an extracellular ma-
trix-binding protein homologue (34). Although not docu-
mented in the literature, additional proteins with Sec-type sig-
nal peptides and potential cell wall binding repeats can be
recognized readily. These are the cell wall surface anchor fam-
ily protein SACOL2505 and the methicillin-resistant surface
protein SACOL0050, which both contain C-terminal repeat
regions of 130 amino acids. The latter protein, which shows
a high degree of sequence similarity to the SACOL2505 pro-
tein, is found only in S. aureus COL, not in the five other
sequenced strains. This is due to the fact that the gene for
SACOL0050 is localized on mec cassette 1 and therefore not
present in the other strains. Notably, the SACOL2505 homo-
logues in S. aureus Mu50 and N315 seem to lack the C-terminal
part of the protein with the repeats. A close inspection of the
sequences of the corresponding genes in these strains revealed
that there is a frameshift mutation or sequencing error in these
genes, resulting in an apparent or real C-terminal truncation of
the corresponding proteins. Thus, the C-terminal cell wall
binding repeats are absent or appear to be absent. Interest-
ingly, most of the aforementioned proteins with cell wall bind-
ing motifs also contain the motif LPXTG for covalent attach-
ment to the cell wall by sortase A or sortase B (see below).
It should be noted that a variety of known cell wall binding
domains, such as the choline binding domain (205), the Cpl-7
cell wall binding domain (59), and the fructosyltransferase cell
wall binding domain (81, 122, 151), appear to be absent from
staphylococcal proteins.
Covalent attachment to the cell wall. Cell wall sorting pro-
teins, known as sortases, exist in many gram-positive bacteria
and serve to anchor proteins that are destined for cell surface
display to the cell wall (50, 182). In almost all gram-positive
bacteria, there is at least one sortase present, and often genes
for more than one sortase-like protein can be detected in a
single genome. These transpeptidases catalyze the formation
of an amide bond between the carboxyl group of a Thr and the
free amino end of pentaglycine cross bridges in peptidoglycan
precursors. Subsequently, the peptidoglycan precursors with
covalently bound proteins are incorporated into the cell wall.
More recently, it was shown that sortases can also be involved
in protein polymerization, leading to the assembly of pili on the
surfaces of gram-positive bacteria, such as Corynebacterium
diphtheriae (61, 182). The three-dimensional structure of
sortase A (SrtA) of S. aureus revealed that this protein has a
unique -barrel structure in which a catalytic Cys residue is
positioned close to a His residue. This suggests that sortase A
forms a thiolate-imidazolium ion pair for catalysis (83, 183).
Furthermore, it has been shown that a conserved Arg residue
is needed for efficient catalysis (112). The catalytic cysteine is
part of a conserved motif, TLXTC, which can be found in the
C-terminal part of the protein (X is usually Val, Thr, or Ile).
Recently, a classification of sortases was proposed by Dramsi
et al. (50), based on phylogenetic analyses of 61 sortases that
are encoded by the genomes of 22 gram-positive bacteria.
These analyses showed that sortases can be grouped into four
different classes (A to D). Class A consists of sortases from
many low-GC% gram-positive bacteria, including L. monocyto-
genes, Streptococcus pyogenes, and S. aureus. The second class
(class B) is present in only a few low-GC% gram-positive
bacteria, including L. monocytogenes, B. anthracis, and S. aureus.
Sortases of this class contain three amino acid segments that
are not present in the sortases of class A. These sortases
recognize a different motif (NPQTN in S. aureus). The genes
for substrates of class B sortases are often found at the same
locus as the sortase gene. The largest class (class C) consists of
sortases from high-GC% and low-GC% gram-positive bacte-
ria. The genes for class C sortases are often present in multiple
copies per genome. The characteristics of this class of sortases
include a C-terminal hydrophobic domain that might serve as
a membrane anchor and a conserved proline residue behind
the catalytic site. Finally, class D sortases are present in high-
and low-GC% gram-positive bacteria. This class can be divided
into three subclusters, depending on whether the sortases are
present in bacilli, clostridia, or actinomycetes. Since class C
and D sortases are absent from S. aureus, the (potential) sub-
strates of these enzymes are not reviewed here.
(i) Sortase A recognition signal. For interaction with host
cells during infection, many proteins are anchored to the cell
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walls of staphylococcal cells, thereby enabling the cells to ad-
here to and invade the host cells or to evade the immune
system. Many of these proteins contain an LPXTG motif in
their C-terminal part, which is recognized by the cell wall
sorting protein sortase A. In each of the six sequenced S.
aureus strains, there is only one sortase gene present, which
encodes a class A sortase. The LPXTG motif of sortase A
substrates is followed by a stretch of hydrophobic amino acids
and at least one positively charged amino acid (Lys or Arg) at
the C terminus. After protein translocation across the mem-
brane, the LPXTG motif is recognized by SrtA and subse-
quently cleaved between the Thr and Gly residues (115, 131).
Transpeptidation is then mediated by SrtA through amide
linkage of the C-terminal Thr of the protein to pentaglycine
cross bridges. It has been suggested that SrtA actually uses
lipid II as a peptidoglycan substrate and that the proteins
linked to lipid II are subsequently incorporated into the cell
wall. In addition to the canonical LPXTG motif, an LPXAG
motif can also be recognized and cleaved by SrtA (156).
It has been reported that S. aureus has 19 proteins that carry
the LPXTG motif and 2 proteins that carry the LPXAG motif
at their C termini (156). Many of these proteins have been
shown to be expressed. These include protein A (Spa), two
clumping factors (ClfA and ClfB; also contain potential wall
binding repeats), a collagen-binding protein (Cna), three
serine-aspartate repeat proteins (SdrC, SdrD, and SdrE; also
contain potential wall binding repeats), two fibronectin-bind-
ing proteins (FnbpA and FnbpB) (reviewed by Foster and
Hook [58]), a plasmin-sensitive protein (Pls) (163), FmtB (98),
and several S. aureus surface (Sas) proteins (156). A recent
study on the cell wall and membrane proteome by Nandakumar
et al. (127) resulted in the identification of two proteins with an
LPXTG cell wall sorting signal. Many of the LPXTG-containing
proteins contain a conserved motif, (YF)-SIRK (with some
variance), in their N-terminal signal peptides, which has also
been observed for other proteins that are substrates for SrtA in
several gram-positive bacteria (9). However, this sequence is
not found in all SrtA substrates and can also be found in
non-cell-wall proteins. This suggests that (YF)-SIRK is not a
specific SrtA targeting sequence. One of the sas genes, sasA, is
situated in the secA2/secY2 cluster and has an unusually long
signal peptide (90 residues), which might indicate that the
accessory SecA2/SecY2 system is needed for the transport
of SasA across the membrane. If so, this would be similar to
the case reported for the cell wall-bound GspB protein of S.
gordonii (13).
Depending on the sequenced S. aureus strain, 10 to 13 pro-
teins with an LPXTG cell wall sorting signal followed by a
hydrophobic stretch of residues and a positively charged C
terminus can be found (Table 10). Among these proteins are
fibrinogen-binding protein A (ClfA), the immunoglobulin G
binding protein A precursor (Spa), and the Ser-Asp-rich,
fibrinogen-binding bone sialoprotein-binding protein (SdrC).
Five additional proteins (SdrD, SdrE, SasC, FnbA, and FnbB)
with an LPXTG motif can be found among the S. aureus strains
(Table 10). These five proteins were excluded from our ini-
tial list because the corresponding SignalP scores were lower
than our (high) score criterion. However, since some of the
domains present in these proteins (besides the LPXTG mo-
tif) are conserved in well-described cell wall proteins, they
were included in Table 10. The remaining proteins with a
cell wall sorting signal either are missing in one or more S.
aureus strains or have been annotated wrongly. Interest-
ingly, S. epidermidis ATCC 12228 contains a gene for a class
C sortase (srtC) which seems to be absent from other staph-
ylococci. This SrtC protein is most closely related to sortases
of L. lactis and Streptococcus suis. Two proteins with
LPXTG motifs which are encoded by the same genomic
island as SrtC also seem to be strain specific (63).
(ii) Sortase B recognition signal. All sequenced S. aureus
strains contain sortase B (SrtB) in addition to SrtA. The gene
for SrtB is situated at a locus which is involved in the uptake of
heme iron (116). This locus also contains the gene for the cell
wall protein IsdC, which contains the SrtB recognition se-
quence NPQTN. In addition, this locus contains the genes for
the SrtA substrates IsdA and IsdB, which both contain LPXTG
motifs. Notably, IsdC is so far the only protein known to be
anchored to the cell wall by sortase B. IsdC is cleaved by SrtB
between the Thr and Asn residues of the NPQTN motif. The
only other S. aureus protein with a motif that resembles
NPQTN is the DNA-binding protein II, but this protein is
probably not cell wall bound because it lacks a signal peptide
for export from the cytoplasm.
COMPARATIVE SECRETOME ANALYSIS
Comparison of the predicted secretomes of S. aureus and S.
epidermidis with those of B. subtilis and other gram-positive
bacteria revealed that most of the known components of the
translocation machinery are present in S. aureus. The most
notable differences are the second set of secA and secY genes
in S. aureus, the absence of known signal peptide peptidases
from S. aureus and S. epidermidis, the absence of a BdbC
homologue from S. aureus and S. epidermidis, the presence of
a second lspA gene in S. epidermidis, the absence of a Tat
system from S. epidermidis, and the absence of two potential
components in the ESAT-6 pathway from S. aureus MRSA252
(Table 3). So far, no evidence has been published on whether
SecA2 and SecY2 are involved in the export of important
virulence factors in S. aureus. However, it has been shown that
the second secA/secY set is involved in the export of virulence
factors in other pathogens (172). Although most known deter-
minants for protein export, processing, and posttranslocational
modification in other gram-positive bacteria are also present in
S. aureus, in many cases it remains to be investigated to what
extent they are necessary for protein export in general and the
export of virulence factors in particular.
As shown by multiple BLAST comparisons, the core exo-
proteome of the sequenced S. aureus strains consists of 58
proteins (Table 6). All of these proteins have a signal peptide
with a potential SpsB recognition and cleavage site. Thirty-
three of these core exoproteins have already been identified in
the extracellular milieus and/or membrane/cell wall proteomes
of different S. aureus isolates (127, 208). Interestingly, 26 core
exoproteins of S. aureus are also conserved in S. epidermidis,
suggesting that they belong to a core staphylococcal exopro-
teome, which is presently still poorly defined. Interestingly, the
core exoproteome of S. aureus seems to be largely composed of
enzymes, such as proteases, and other factors, such as fibrin-
ogen- and IgG-binding proteins, that are required for life in
VOL. 70, 2006 SECRETOMICS OF STAPHYLOCOCCAL PATHOGENESIS 779
 o
n









the ecological niches provided by the human host (Table 6).
This is particularly true for the proteins that have the potential
to be covalently bound to the cell wall (Table 10). In contrast,
the variant exoproteome of S. aureus contains most of the
known staphylococcal toxins and immunomodulating factors
(Tables 7 and 11). This suggests that the components of the
variant exoproteome should be regarded as specific gadgets of
S. aureus that help this organism to conquer certain protected
niches of the human host, thereby causing disease. If this idea
is correct, then proteins of unknown function that belong to
the variant exoproteome should be regarded as potentially
important virulence factors.
The (predicted) extracellular toxins of S. aureus are not
present in S. epidermidis. This is mainly due to the fact that
these toxins are encoded by pathogenicity islands in the ge-
nomes of S. aureus strains that have thus far not been observed
in S. epidermidis genomes. Proteins with predicted signal pep-
tides that are specific for S. epidermidis are listed in Table 12.
Notably, the majority (i.e., 26 of 30) of predicted S. epidermidis
exoproteins that have homologues in S. aureus share this ho-
mology with components of the core exoproteome of S. aureus
(Tables 6 and 7). This suggests that in S. epidermidis, the core
exoproteome is also involved in housekeeping functions. In
contrast to the case for the exoproteome, it is presently difficult
to speculate about housekeeping and disease-causing roles of
the constant and variant lipoproteomes of S. aureus. This is due
to the fact that the functions of only a few S. aureus lipopro-
teins are known (Tables 8, 9, and 13). In general terms, it is
presently not clear why S. epidermidis seems to export a
smaller number of different proteins (101 in total) than does
S. aureus (135 in total). This difference is all the more
remarkable since the total numbers of proteins encoded by
the genomes of S. aureus (2,600) and S. epidermidis
(2,500) are comparable.
Compared to B. subtilis and B. licheniformis (193), S. aureus
is also predicted to export a relatively large number of proteins
from the cytoplasm to the membrane-cell wall interface, the
cell wall, and the extracellular milieu. The genomes of B.
subtilis and B. licheniformis contain 4,100 protein-encoding
genes, while S. aureus genomes contain significantly fewer
genes (2,600). Using the most recent prediction protocols
(179), B. subtilis is predicted to export 190 proteins to an
extracytoplasmic location, whereas, depending on the strain
investigated, S. aureus is predicted to export 130 to 145 pro-
teins (this review). Accordingly, as judged by the relative num-
bers of protein-encoding genes, S. aureus strains appear to
TABLE 10. Staphylococcal proteins with (potential) Sec-type signal peptides and (potential) signals for covalent cell wall binding
Identification no. Protein Function Signal
15925728 SA0022 Hypothetical protein, similar to 5-nucleotidase LPKTG
15925815 Spa Immunoglobulin G binding protein A precursor LPETG
15925838 SasD Hypothetical protein LPAAG
15926239a SdrC Ser-Asp-rich, fibrinogen-binding bone sialoprotein-binding protein LPETG
15926240b,c SdrD Ser-Asp-rich, fibrinogen-binding bone sialoprotein-binding protein LPETG
15926241a,c SdrE Ser-Asp-rich, fibrinogen-binding bone sialoprotein-binding protein LPETG
15926464 ClfA Fibrinogen-binding protein A, clumping factor LPDTG
15926713 IsdB Conserved hypothetical protein LPKTG
15926714 IsdA Cell surface protein LPKTG
15926715 IsdC Conserved hypothetical protein NPQTN
15927308b HarA Hypothetical protein LPKTG
15927333c,d SasC Hypothetical protein, similar to FmtB protein LPNTG
15927741a,e SasB FmtB protein LPDTG
15928076 a, b, f Aap Hypothetical protein, similar to accumulation-associated protein LPKTG
15928081b,c FnbB Fibronectin-binding protein homolog LPETG
15928082c FnbA Fibronectin-binding protein homolog LPETG
15928174g SasK Hypothetical protein LPKTG
15928216 ClfB Clumping factor B LPETG
15928232a SasF Conserved hypothetical protein LPKAG
15928240h SasA Hypothetical protein, similar to streptococcal hemagglutinin protein LPDTG
57652419 i Pls Methicillin-resistant surface protein LPDTG
21284341j Cna Collagen adhesin precursor LPKTG
27467746k SE0828 Lipoprotein VsaC LPETG
27468418k SE1500 Hypothetical protein LPKTG
27468419k SE1501 Hypothetical protein LPNTG
27468546k SE1628 Hypothetical protein LPETG
27469070k SE2152 Hypothetical protein LPNTG
a Also present in S. epidermidis.
b The genes encoding SdrC, HarA, and FnbB are not present in S. aureus MRSA252.
c Has a lower SignalP score than our threshold score.
d Truncated in S. aureus Mu50, thereby missing the C-terminal part containing the LPXTG motif.
e The gene encoding SasB is not present in S. aureus MRSA252 and MSSA476 and is truncated in S. aureus MW2.
f Truncated in S. aureus Mu50 and N315, thereby missing the C-terminal part containing the LPXTG motif.
g The gene encoding SasK is not present in S. aureus COL, MRSA252, and MSSA476 and is truncated in S. aureus MW2, thereby missing the N-terminal signal
peptide.
h Contains an unusually long signal peptide (90 amino acids).
i The gene encoding Pls is present only in S. aureus COL.
j The gene encoding Cna is not present in S. aureus COL, Mu50, and N315.
k Present only in S. epidermidis.
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TABLE 11. Composition of the variant exoproteome of sequenced S. aureus strains
Identification
no. Protein Function
Presence of protein in straina
COL MRSA252 MSSA476 Mu50 MW2 N315
15925799 Plc 1-Phosphatidylinositol phosphodiesterase
precursor
Y Y N Y Y Y
15926099 Set6 Exotoxin 6 N N N Y N Y
15926100 Set7 Exotoxin 7 Y N Y Y Y Y
15926101 Set8 Exotoxin 8 N N Y Y Y Y
15926103 Set10 Exotoxin 10 N Y Y Y Y Y
15926104 Set11 Exotoxin 11 N Y Y Y Y Y
15926105 Set12 Exotoxin 12 N N Y Y Y Y
15926106 Set13 Exotoxin 13 Yb Y Y Y Y Y
15926111 Set15 Exotoxin 15 N N N Y N Y
15926113 SA0395 Hypothetical protein Y Y Y N Y Y
15926465 SA0743 Hypothetical protein Y N Y Y Y Y
15926739 SA1001 Hypothetical protein Y N Y Y Y Y
15926746 HlY -Hemolysin precursor Y N Y Y Y Y
15927016 EbhB Hypothetical protein Y Y N Y Y Y
15927308 Fhs Hypothetical protein Y N Y Y Y Y
15927386 SplB Serine protease SplB Y N Y Y Y Y
15927387 SplA Serine protease SplA Y N Y Y Y Y
15927389 SA1633 Probable -lactamase N N N Y N Y
15927393 LukD Leukotoxin, LukD Y N Y Y Y Y
15927398 SEG Extracellular enterotoxin type G precursor N Y N Y N Y
15927399 SEN Enterotoxin SEN N Y N Y N Y
15927402 SEI Extracellular enterotoxin type I precursor N Y N Y N Y
15927404 SEO Enterotoxin SEO N Y N Y N Y
15927512 Map Truncated MapW protein Y Y N Y Y Y
15927513 Hlb -Hemolysin/phospholipase C Y N N Y Y Y
15927516 SA1754 Hypothetical protein N Y Y Y Y Y
15927517 SA1755 Hypothetical protein N Y N N N Y
15927520 Sak Staphylokinase precursor N Y Y Y Y Y
15927522 SA1760 Hypothetical protein N Y Y Y Y Y
15927585 SEC3 Enterotoxin type C3 Y Y N Y Y Y
15927586 SA1818 Hypothetical protein Y N N Y Y Y
15927587 TSST-1 Toxic shock syndrome toxin 1 N N N Y N Y
15927741 FmtB FmtB protein Y N N Y Y Y
15928076 SA228 Hypothetical protein Y N Y Y Y Y
15928174 SA2381 Hypothetical protein N N Y Y Y Y
15928182 SA2389 Hypothetical protein N N N Y N Y
16119219 SAP019 Hypothetical protein N Y Y N N Y
14141830 SAVP008 Hypothetical protein N N N Y N N
21282111 Set16 Hypothetical protein N Y Y N Y N
21282116 Set21 Hypothetical protein N N Y N Y N
21282123 Set26 Hypothetical protein N Y Y N Y N
21283107 LukF Panton-Valentine leukocidin chain F
precursor
N N N N Y N
21283108 LukS Panton-Valentine leukocidin chain S
precursor
N N N N Y N
21284341 Cna Collagen adhesin precursor N Y Y N Y N
49482651 SAR0423 Exotoxin N Y N N N N
49482652 SAR0424 Exotoxin N Y N N N N
49482653 SAR0425 Exotoxin N Y N N N N
49482925 SAR0721 Multicopper oxidase protein N Y N N N N
49484047 SAR1886 Putative exported protein N Y N N N N
49484059 SAR1905 Serine protease N Y N N N N
49484898 SAR2788 Putative exported protein N Y N N N N
49484957 SEH Enterotoxin H N N Y N Y N
49485293 SAS0389 Exotoxin N N Y N Y N
57650600 SACOL1865 Serine protease SplE, putative Y Y N N N N
57650605 SACOL1870 Hypothetical protein Y N Y N Y N
57650609 EpiP Epidermin leader peptide processing serine
protease EpiP
Y N Y N Y N
57651309 SACOL0468 Exotoxin 3, putative Y N N N N N
57651311 SACOL0470 Exotoxin, putative Y N N N N N
57651319 SACOL0478 Exotoxin 3, putative Y N N N N N
57652419 Pls Methicillin-resistant surface protein Y N N N N N
a Y, yes; N, no.
b This protein has a Thr at the 1 position, which is not included in the SpsB recognition and cleavage pattern. All other S. aureus strains conform to the proposed
pattern.
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export 6 to 20% more proteins to an extracytoplasmic location
than do the aforementioned bacilli. Most probably, this is re-
lated to the fact that S. aureus needs an arsenal of virulence
factors, such as toxins and surface proteins, for colonization of
and survival in its preferred niches in the human host. Such
proteins are of less importance for soil bacteria, such as B.
subtilis and B. licheniformis, which thrive predominantly on
dead organic matter.
PERSPECTIVES
The present review provides a survey of possible protein
transport pathways in staphylococcal pathogenesis. In many
cases, the knowledge gathered from protein secretion studies
in other organisms has been projected on S. aureus, assuming
that similar pathways or pathway components have similar
functions in different organisms. Clearly, this leaves room for
surprises when such pathways are investigated thoroughly for
S. aureus. The same was true for studies on protein secretion in
B. subtilis. These studies showed, for example, that the absence
of SecDF has barely any consequences for protein secretion by
B. subtilis, whereas SecD and SecF are of key importance for
protein translocation in E. coli, the organism in which SecD/F
was first discovered (20). Likewise, LspA was shown to be
dispensable in B. subtilis but not in E. coli (147, 177). Thus, the
relative importance of different secretion machinery compo-
nents of S. aureus needs to be assessed in a systematic manner,
preferably in an isogenic background. Such studies would need
to address the importance of secretion machinery components
for in vitro growth on different substrates (e.g., broth or blood)
and for virulence in vivo in model systems (e.g., C. elegans,
Drosophila melanogaster, mice, or rats) (8, 60, 173). These
studies should be complemented with proteomic verification of
our present lipoproteome, wall proteome, and exoproteome
predictions. Such a verification could involve both gel-based
proteomics approaches, as outlined in this review, and more
sophisticated gel-free proteomics approaches (194). This
would lead to an improved understanding of the contribution





Amino acid at position:
Function
3 2 1 1 2
Sec 27466926a SE0008 T Y A S Truncated -hemolysin
27467163 SE0245 V H A A Triacylglycerol lipase precursor
27467176 SE0258 A K A Q Immunodominant antigen B
27467249 b, c SE0331 A K A E Ser-Asp-rich, fibrinogen-binding bone
sialoprotein-binding protein
27467501a SE0583 S F A N Hypothetical protein
27467545a SE0627 T L A D Poly-D-alanine transfer protein
27467746b SE0828 A H A E Lipoprotein VsaC
27467938a SE1020 I K A Q Hypothetical protein
27468418b SE1500 S Y A Q Hypothetical protein
27468493 SE1575 A Q A H Immunodominant antigen B
27468546b SE1628 V Y A D Hypothetical protein
27468801a SE1883 V S A K Lyt divergon expression attenuator LytR
27468838 SE1920 V Y A Q Hypothetical protein
27469060a SE2142 T L A F 2-Dehydropantoate 2-reductase
27469070b SE2152 T H A A Hypothetical protein
27469115a SE2197 S Y A S Alkaline phosphatase III precursor
27469119 SE2201 A D A Z Phage-related protein
27469291 SE2373 A Q A S 1,4--N-Acetylmuramidase
27469316 SE2398 S S A S Hypothetical protein
32470521 P601 A S A S Hypothetical protein
32470527 P607 I N A D Hypothetical protein
32470549b P517 A K A E Hypothetical protein
32470583 P202 T F A L Hypothetical protein
Lipoprotein 27466952 SE0034 L S A C S Hypothetical protein
27467000 SE0082 L T A C G Hypothetical protein
27467062 SE0144 V S G C G Hypothetical protein
27467063 SE0145 V S G C G Hypothetical protein
27467067 d SE0149 L A G C D Hypothetical protein
27467309d SE0391 L T T C S Hypothetical protein
27468024 SE1106 V T A C S ABC transporter
27468425d SE1507 L Y G C G Hypothetical protein
27469012d SE2094 L I I C S Hypothetical protein
27469069d SE2151 L A G C G Hypothetical protein
27469130 SE2212 V S G C S Hypothetical protein
27469141d SE2223 L G S C S Hypothetical protein
27469317 SE2399 L S A C G Hypothetical protein
a All S. aureus strains have one or more residues in the cleavage site which are not included in the search pattern.
b Contains an LPXTG motif.
c Has a lower SignalP score than our threshold score for all S. aureus strains.
d Excluded for S. epidermidis because of the motif proposed by Sutcliffe and Harrington (171).
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of each protein transport pathway and its substrate proteins to
staphylococcal cell physiology and virulence. Since the viru-
lence of different S. aureus strains will depend not only on the
presence (or absence) of particular genes for virulence factors
but also on their expression, such proteomic studies should
also include experiments on the impacts of major regulatory
systems, such as agr, sae, and sarA. On this basis, it should be
possible to identify the most promising candidate drug targets
in the staphylococcal secretome. Alternatively, secretome com-
ponents thus identified could represent promising candidates
for novel vaccines. For all of these efforts, comparative secre-
tomics approaches will provide essential information on those
potential drug targets that are most important for both bacte-
rial housekeeping functions and virulence. Novel drugs and
vaccines designed against these targets are likely to have the
highest impact (65).
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TABLE 13. Composition of the variant lipoproteome of sequenced S. aureus strains
Identification
no. Protein Function
Presence of protein in straina
COL MRSA252 MSSA476 Mu50 MW2 N315
15925801 SA0093 Hypothetical protein N N N Y N Y
15925803 SA0095 Hypothetical protein N N N Y N Y
15925804 SA0096 Hypothetical protein Y N N Y N Y
15925877 SA0167 Hypothetical protein N Y Y Y Y Y
15926004 SA0291 Hypothetical protein Y N Y Y Y Y
15926114 Lpl1 Hypothetical protein Y Y N Y N Y
19526115 Lpl2 Hypothetical protein N N N Y N Y
15926116 Lpl3 Hypothetical protein Y N N Y N Y
15926118 Lpl4 Hypothetical protein N N N Y N Y
15926119 Lpl5 Hypothetical protein N N N Y N Y
15926120 Lpl6 Hypothetical protein N N Y Y Y Y
15926122 Lpl8 Hypothetical protein Y Y N Y N Y
15926123 Lpl9 Hypothetical protein Y Y Y Y N Y
15926465 SA0743 Hypothetical protein, similar to staphylocoagulase
precursor
Y N Y Y Y Y
15926580 SA0850 Hypothetical protein, similar to oligopeptide ABC
transporter oligopeptide-binding protein
Y N Y Y Y Y
15927067 SA1317 Hypothetical protein N N N Y N Y
15927068 SA1318 Hypothetical protein N N Y Y Y Y
15927069 SA1319 Hypothetical protein N Y Y Y Y Y
15927373 SA1617 Hypothetical protein, similar to latent nuclear
antigen
Y Y Y Y Y Y
15927396 SA1640 Conserved hypothetical protein N N N Y N Y
15927859 ModA Probable molybdate-binding protein Y Y Y N Y Y
15928064 SA2273 Hypothetical protein Y N N Y N Y
21281801 MW0072 Hypothetical protein Y N Y N Y N
21282126 Lpl10 Hypothetical protein Y Y Y N Y N
21282127 Lpl11 Hypothetical protein N Y Y N Y N
21282129 Lpl13 Hypothetical protein N N Y N Y N
21283103 MW1374 Conserved hypothetical protein N N Y N Y N
21283167 MW1438 Hypothetical protein N Y Y N Y N
21284135 MW2406 Hypothetical protein N N Y N Y N
21284306 MW2577 Hypothetical protein N N Y N Y N
49482670 SAR0445 Putative lipoprotein N Y N N N N
49483993 BlaZ -Lactamase precursor N Y N N N N
49484246 SAR2104 Putative lipoprotein N Y N Y N N
49484287 SAR2149 Putative exported protein N Y N N N N
49484977 SAS0074 Putative lipoprotein N N Y N N N
57650161 SACOL0888 Pathogenicity island, putative lipoprotein Y N N N N N
57650441 SACOL1528 Hypothetical protein SA1528 Y Y N N N N
57650444 SACOL1531 Hypothetical protein SA1531 Y N N N N N
57650485 SACOL1574 Hypothetical protein SA1574 Y Y N N N N
57650696 SACOL2010 Iron compound ABC transporter, iron compound-
binding protein
Y N Y Y Y N
57651323 SACOL0482 Staphylococcus tandem lipoprotein Y N N N N N
57652445 SACOL0081 Hypothetical protein SA0081 Y N N N N N
14141829 SAVP006 Hypothetical protein N N N Y N N
a Y, yes; N, no.
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